<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" version="2.0">
 
  <channel>
    <title>Johnny Silva Cancer Research</title>
    <link>http://www.johnnysilva.com</link>
    <language>en-en</language>
    <pubDate>Wed, 22 Feb 2012 21:47:49 GMT</pubDate>

<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/CancerResearcher" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="cancerresearcher" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><creativeCommons:license>http://creativecommons.org/licenses/by/2.0/</creativeCommons:license><item>
 <title>Key components of the compound microscope NuclearMatrix</title>
 <description>The eyepieces, body tube, nosepiece and objectives are part of the magnification system of the microscope. The condenser, condenser-iris diaphragm, filters, field iris diaphragm and light source are the parts that compose the illumination system of the microscope. To use a microscope properly, and to get the most out of it, it is important to understand the purpose and function of each of the microscope's components Figure 1.2 . The binocular body, the arm and the base form the frame of the...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/nuclear-matrix/key-components-of-the-compound-microscope.html"&gt;&lt;img src="http://www.johnnysilva.com/nuclear-matrix/images/2057_5_4.jpg" style="width: 332pt; height: 389pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=gT2Cr3sicnE:icD_1upB87Y:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=gT2Cr3sicnE:icD_1upB87Y:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=gT2Cr3sicnE:icD_1upB87Y:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=gT2Cr3sicnE:icD_1upB87Y:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=gT2Cr3sicnE:icD_1upB87Y:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=gT2Cr3sicnE:icD_1upB87Y:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>NuclearMatrix</category>
 <link>http://www.johnnysilva.com/nuclear-matrix/key-components-of-the-compound-microscope.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/nuclear-matrix/key-components-of-the-compound-microscope.html</guid>
 <media:content url="http://www.johnnysilva.com/nuclear-matrix/images/2057_5_4.jpg" type="image/jpeg" height="545" width="465" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 21:47:49 GMT</pubDate>
</item>
<item>
 <title>Consolidation Therapy CellTransplantation</title>
 <description>The choice of appropriate postremission therapy will depend on the patient's risk of relapse, which can be estimated based on presenting WBC and platelet counts.4 APL patients in low- and intermediate-risk groups can generally be successfully consolidated with anthracyclines alone. In recent trials published by the PETHEMA and GIMEMA groups, relapse rates of patients in low and intermediate risk groups were less than 10 , following consolidation with anthracyclines plus ATRA or anthracycline...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BQLnNFhau3A:4k4ddhuQjvU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BQLnNFhau3A:4k4ddhuQjvU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=BQLnNFhau3A:4k4ddhuQjvU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BQLnNFhau3A:4k4ddhuQjvU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=BQLnNFhau3A:4k4ddhuQjvU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BQLnNFhau3A:4k4ddhuQjvU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CellTransplantation</category>
 <link>http://www.johnnysilva.com/cell-transplantation/consolidation-therapy.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cell-transplantation/consolidation-therapy.html</guid>
 <pubDate>Wed, 22 Feb 2012 21:18:28 GMT</pubDate>
</item>
<item>
 <title>Problems 1 BioanalyticalChemistry</title>
 <description>1. The enzyme alanopine dehydrogenase reversibly catalyzes the reaction shown below. It is present in bivalve molluscs, such as the periwinkle, that live in intertidal regions. These species survive exposure during low tides through valve closure, and their metabolism switches from the aerobic lactate dehydrogenase pathway to the anaerobic alanopine dehydrogenase pathway. Exposed mollusks accumulate alanopine in their tissues, and alanopine levels have been related to exposure times. NH CH CH3...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Qg3Vu4WUjo8:mlq1Hsej2U0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Qg3Vu4WUjo8:mlq1Hsej2U0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Qg3Vu4WUjo8:mlq1Hsej2U0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Qg3Vu4WUjo8:mlq1Hsej2U0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Qg3Vu4WUjo8:mlq1Hsej2U0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Qg3Vu4WUjo8:mlq1Hsej2U0:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BioanalyticalChemistry</category>
 <link>http://www.johnnysilva.com/bioanalytical-chemistry/problems-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/bioanalytical-chemistry/problems-1.html</guid>
 <pubDate>Wed, 22 Feb 2012 20:53:43 GMT</pubDate>
</item>
<item>
 <title>Principles Of Microscopy EndoplasmicReticulum</title>
 <description>Microscopes make small objects appear bigger. A light microscope will magnify an image up to 1500 times its original size. Electron microscopes can achieve magnifications up to 1 million times. However, bigger is only better when more details are revealed. The fineness of detail that a microscope can reveal is its resolving power. This is defined as the smallest distance that two objects can approach one another yet still be recognized as being separate. The resolution that a microscope...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/endoplasmic-reticulum/principles-of-microscopy.html"&gt;&lt;img src="http://www.johnnysilva.com/endoplasmic-reticulum/images/2056_7_2.jpg" style="width: 332pt; height: 416pt;" title="Figure Cell structure seen through the light and transmission electron microscopes"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l9hOodqvLgY:kb8hGRgtA4g:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l9hOodqvLgY:kb8hGRgtA4g:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=l9hOodqvLgY:kb8hGRgtA4g:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l9hOodqvLgY:kb8hGRgtA4g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=l9hOodqvLgY:kb8hGRgtA4g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l9hOodqvLgY:kb8hGRgtA4g:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>EndoplasmicReticulum</category>
 <link>http://www.johnnysilva.com/endoplasmic-reticulum/principles-of-microscopy.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/endoplasmic-reticulum/principles-of-microscopy.html</guid>
 <media:content url="http://www.johnnysilva.com/endoplasmic-reticulum/images/2056_7_2.jpg" type="image/jpeg" height="582" width="465" />
 <media:title />
 <media:description type="html">Figure Cell structure seen through the light and transmission electron microscopes</media:description>
 <pubDate>Wed, 22 Feb 2012 20:44:14 GMT</pubDate>
</item>
<item>
 <title>APPROACH TO SUSPECTED HEPATITIS Viral Hepatitis ClinicalPearls</title>
 <description>Most cases of acute hepatitis are caused by infection with one of five viruses hepatitis A. B. C, D, or E. They can produce virtually indistinguishable clinical syndromes, although it is unusual to observe acute hepatitis C. Affected individuals often complain of a prodrome of nonspecific constitutional symptoms, including fever, nausea, fatigue, arthralgias, myalgias, headache, and sometimes pharyngitis and coryza. This is followed by the onset of visible jaundice caused by hyperbilirubinemia,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LEV5DPT1jJc:MiEukmkTBuA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LEV5DPT1jJc:MiEukmkTBuA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LEV5DPT1jJc:MiEukmkTBuA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LEV5DPT1jJc:MiEukmkTBuA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LEV5DPT1jJc:MiEukmkTBuA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LEV5DPT1jJc:MiEukmkTBuA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ClinicalPearls</category>
 <link>http://www.johnnysilva.com/clinical-pearls/approach-to-suspected-hepatitis-viral-hepatitis.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/clinical-pearls/approach-to-suspected-hepatitis-viral-hepatitis.html</guid>
 <pubDate>Wed, 22 Feb 2012 20:03:57 GMT</pubDate>
</item>
<item>
 <title>Orthodontic Treatment Of Osseous Defects PeriodontalDisease</title>
 <description>lletnisepl.il defects are one- or two-wall osseous detects that often are found around mcsially tipped teeth d ig. 5A U or teeth that have supererupted Fig. SA-4 . I suallv. these defects can be eliminated with the appropriate orthodontic treatment. In the case ol the tipped tooth, up-righting' ' and eruption ol the tooth levels the bony deled. II the tooth is supererupted. intrusion and leveling of the adjacent cementoenamel junctions can help level the osseous clefec I. It is imperative that...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/periodontal-disease/orthodontic-treatment-of-osseous-defects.html"&gt;&lt;img src="http://www.johnnysilva.com/periodontal-disease/images/2051_562_783.jpg" style="width: 367pt; height: 168pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Vn52C2ygL-E:4F7-KA89VUQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Vn52C2ygL-E:4F7-KA89VUQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Vn52C2ygL-E:4F7-KA89VUQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Vn52C2ygL-E:4F7-KA89VUQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Vn52C2ygL-E:4F7-KA89VUQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Vn52C2ygL-E:4F7-KA89VUQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PeriodontalDisease</category>
 <link>http://www.johnnysilva.com/periodontal-disease/orthodontic-treatment-of-osseous-defects.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/periodontal-disease/orthodontic-treatment-of-osseous-defects.html</guid>
 <media:content url="http://www.johnnysilva.com/periodontal-disease/images/2051_562_783.jpg" type="image/jpeg" height="235" width="514" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 19:55:24 GMT</pubDate>
</item>
<item>
 <title>Prediction Marginalization of Nuisance Parameters and Class Comparison Neural Networks 2</title>
 <description>Consider a prediction problem in which we are trying to predict the output value y of an unknown parameterized function fw, given an input . It is easy to show that the optimal prediction is given by the expectation This integral is the average of the predictions made by each possible model fw, weighted by the plausibility P w D of each model. Another example is the process of marginalization, where integration of the posterior parameter distribution is carried out only with respect to a subset...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IPASnI8R1ic:TQ9d7gbe5bA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IPASnI8R1ic:TQ9d7gbe5bA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=IPASnI8R1ic:TQ9d7gbe5bA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IPASnI8R1ic:TQ9d7gbe5bA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=IPASnI8R1ic:TQ9d7gbe5bA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IPASnI8R1ic:TQ9d7gbe5bA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <link>http://www.johnnysilva.com/neural-networks-2/prediction-marginalization-of-nuisance-parameters-and-class-comparison.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/neural-networks-2/prediction-marginalization-of-nuisance-parameters-and-class-comparison.html</guid>
 <pubDate>Wed, 22 Feb 2012 19:36:55 GMT</pubDate>
</item>
<item>
 <title>Brain Activity And Positive Arousal IndividualDifferences</title>
 <description>Armed with neural probes of reward processing, we could begin to examine the relationship between NA activation and positive arousal across individuals. PET research from a number of laboratories suggested not only that injections of amphetamine could powerfully induce positive arousal e.g., euphoria in some subjects, but also that individual differences in the degree to which subjects experienced positive arousal depended upon the amount of dopamine release in ventral striatal regions such as...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=zQWt6Dy27Hc:WC2PH9wiyjM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=zQWt6Dy27Hc:WC2PH9wiyjM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=zQWt6Dy27Hc:WC2PH9wiyjM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=zQWt6Dy27Hc:WC2PH9wiyjM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=zQWt6Dy27Hc:WC2PH9wiyjM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=zQWt6Dy27Hc:WC2PH9wiyjM:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>IndividualDifferences</category>
 <link>http://www.johnnysilva.com/individual-differences/brain-activity-and-positive-arousal.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/individual-differences/brain-activity-and-positive-arousal.html</guid>
 <pubDate>Wed, 22 Feb 2012 19:26:59 GMT</pubDate>
</item>
<item>
 <title>Notes Yuq BiologicalAging</title>
 <description>1. For human samples, instead of MboI, a mixture of the restriction enzymes HinfI and RsaI may be used to generate TRFs. 2. Instead of sodium citrate, especially in the case of human lymphocytes and bone marrow cells, KCl may be used for hypotonic treatment. Prepare a solution of 70 mM KCl in H2O, and prewarm it to 37 C. 3. As an alternative to this Cy3-labeled PNA probe, an FITC-labeled CCCTAA 3 PNA telomeric probe may be used. However, it should be noted that the emission spectrum of FITC and...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=22FnFnIuHDM:qZYpjqgWjn0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=22FnFnIuHDM:qZYpjqgWjn0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=22FnFnIuHDM:qZYpjqgWjn0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=22FnFnIuHDM:qZYpjqgWjn0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=22FnFnIuHDM:qZYpjqgWjn0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=22FnFnIuHDM:qZYpjqgWjn0:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BiologicalAging</category>
 <link>http://www.johnnysilva.com/biological-aging/notes-yuq.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/biological-aging/notes-yuq.html</guid>
 <pubDate>Wed, 22 Feb 2012 19:15:23 GMT</pubDate>
</item>
<item>
 <title>EM Dusterhoft and G van den Berg 1 CheddarCheese</title>
 <description>A wax coating is normally applied to Gouda-type cheese after ripening 73 , in the case of young cheese at least 25 days after production. For Gouda cheese normally yellow or white wax is used for Edam cheese it is red. This treatment has been used for more than a century to protect the cheese during transport against microbial growth and weight loss due to moisture evaporation. It was, formerly more than nowadays because of better ripening conditions , general practice to wash and dry the often...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=vWMQ_Mj2_t0:ea2xELf26Gk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=vWMQ_Mj2_t0:ea2xELf26Gk:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=vWMQ_Mj2_t0:ea2xELf26Gk:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=vWMQ_Mj2_t0:ea2xELf26Gk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=vWMQ_Mj2_t0:ea2xELf26Gk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=vWMQ_Mj2_t0:ea2xELf26Gk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CheddarCheese</category>
 <link>http://www.johnnysilva.com/cheddar-cheese/em-dusterhoft-and-g-van-den-berg-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cheddar-cheese/em-dusterhoft-and-g-van-den-berg-1.html</guid>
 <pubDate>Wed, 22 Feb 2012 18:20:20 GMT</pubDate>
</item>
<item>
 <title>Sample Dilutions TestMethodology</title>
 <description>Patient samples may require dilution in order to be analyzed correctly. Most procedures are set up with a limited concentration range. Some procedures start with a set dilution such as 1 10. As was discussed earlier with reagent dilutions, dilutions are composed of a certain amount of concentrated sample and a certain amount of diluent mixed together to make a diluted sample. These types of dilutions are usually expressed as a fraction or ratio rather than with units of concentrations. A...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ct2E7pvScQs:YOPA6-8IV0k:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ct2E7pvScQs:YOPA6-8IV0k:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Ct2E7pvScQs:YOPA6-8IV0k:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ct2E7pvScQs:YOPA6-8IV0k:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Ct2E7pvScQs:YOPA6-8IV0k:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ct2E7pvScQs:YOPA6-8IV0k:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TestMethodology</category>
 <link>http://www.johnnysilva.com/test-methodology/sample-dilutions.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/test-methodology/sample-dilutions.html</guid>
 <pubDate>Wed, 22 Feb 2012 17:55:20 GMT</pubDate>
</item>
<item>
 <title>Inchworm Motors GeneticAlgorithms</title>
 <description>The biologic inchworm is a caterpillar of a group of moths called Geomeridae, which has six front legs and four rear legs. Emulating the mobility mechanism of this larva or caterpillar led to the development of motors and linear actuators that are known as inchworms. These commercially available motors are driven by piezoelectric actuators made by Burleigh Instruments and they are capable of moving at a speed of about 2 mm sec with a resolution of nanometers while providing hundreds of...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spl4IL6-teM:i6xmIDdlcHU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spl4IL6-teM:i6xmIDdlcHU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=spl4IL6-teM:i6xmIDdlcHU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spl4IL6-teM:i6xmIDdlcHU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=spl4IL6-teM:i6xmIDdlcHU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spl4IL6-teM:i6xmIDdlcHU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>GeneticAlgorithms</category>
 <link>http://www.johnnysilva.com/genetic-algorithms/inchworm-motors.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/genetic-algorithms/inchworm-motors.html</guid>
 <pubDate>Wed, 22 Feb 2012 17:45:16 GMT</pubDate>
</item>
<item>
 <title>Surgical Intervention Vvp FemoralCondyle</title>
 <description>The patient was indicated for simultaneously performed left knee medial meniscus allograft transplantation and revision ACL reconstruction with bone-patellar tendon-bone allograft. The principal indications for this simultaneous procedure included ipsilateral post-meniscec-tomy pain and recurrent ACL insufficiency. The primary indications for allograft meniscus transplantation included pain and instability, with consideration given to the role of the posterior horn of the medial meniscus as a...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/femoral-condyle/surgical-intervention-vvp.html"&gt;&lt;img src="http://www.johnnysilva.com/femoral-condyle/images/2099_75_94-medial-meniscus-allograft.jpg" style="width: 367pt; height: 309pt;" alt="Medial Meniscus Allograft"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uPTr6-9-0Xo:3aeoE_9yEPA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uPTr6-9-0Xo:3aeoE_9yEPA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=uPTr6-9-0Xo:3aeoE_9yEPA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uPTr6-9-0Xo:3aeoE_9yEPA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=uPTr6-9-0Xo:3aeoE_9yEPA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uPTr6-9-0Xo:3aeoE_9yEPA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>FemoralCondyle</category>
 <link>http://www.johnnysilva.com/femoral-condyle/surgical-intervention-vvp.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/femoral-condyle/surgical-intervention-vvp.html</guid>
 <media:content url="http://www.johnnysilva.com/femoral-condyle/images/2099_75_94-medial-meniscus-allograft.jpg" type="image/jpeg" height="433" width="514" />
 <media:title>Medial Meniscus Allograft</media:title>
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 17:35:01 GMT</pubDate>
</item>
<item>
 <title>Additional Investigations RheumatoidArthritis</title>
 <description>Occasionally a firm diagnosis cannot be made on the basis of the history and clinical examination alone. The following additional investigations are often a Arthroscopy may give much useful information, and in conjunction with the clinical examination will permit a firm, accurate diagnosis to be made in the majority of cases. Incorrect diagnoses are most common in lesions involving the menisci in their posterior thirds. An increasing number of conditions are amenable to arthroscopic surgery,...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/rheumatoid-arthritis/additional-investigations.html"&gt;&lt;img src="http://www.johnnysilva.com/rheumatoid-arthritis/images/2132_40_581.jpg" style="width: 367pt; height: 144pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=w4KPpQVE4vY:nAVXQlzxNvc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=w4KPpQVE4vY:nAVXQlzxNvc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=w4KPpQVE4vY:nAVXQlzxNvc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=w4KPpQVE4vY:nAVXQlzxNvc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=w4KPpQVE4vY:nAVXQlzxNvc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=w4KPpQVE4vY:nAVXQlzxNvc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>RheumatoidArthritis</category>
 <link>http://www.johnnysilva.com/rheumatoid-arthritis/additional-investigations.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/rheumatoid-arthritis/additional-investigations.html</guid>
 <media:content url="http://www.johnnysilva.com/rheumatoid-arthritis/images/2132_40_581.jpg" type="image/jpeg" height="202" width="514" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 17:35:01 GMT</pubDate>
</item>
<item>
 <title>Does High BNP Always Mean High Filling Pressure CardiacTroponin</title>
 <description>Because a major stimulus for the release of BNP is increased wall tension, BNP levels might be expected to correlate with elevated LV filling pressures. However, in the clinical setting there are circumstances in which a high level of BNP is not associated with high left heart filling pressures. These situations include right-sided failure secondary to advanced pulmonary disease, PE, or primary pulmonary hypertension acute or chronic renal failure and rapid lowering of the wedge pressure with...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/cardiac-troponin/does-high-bnp-always-mean-high-filling-pressure.html"&gt;&lt;img src="http://www.johnnysilva.com/cardiac-troponin/images/2041_341_142.jpg" style="width: 281pt; height: 136pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=tK0Aw65vKLs:hgewOrwIufM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=tK0Aw65vKLs:hgewOrwIufM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=tK0Aw65vKLs:hgewOrwIufM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=tK0Aw65vKLs:hgewOrwIufM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=tK0Aw65vKLs:hgewOrwIufM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=tK0Aw65vKLs:hgewOrwIufM:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CardiacTroponin</category>
 <link>http://www.johnnysilva.com/cardiac-troponin/does-high-bnp-always-mean-high-filling-pressure.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cardiac-troponin/does-high-bnp-always-mean-high-filling-pressure.html</guid>
 <media:content url="http://www.johnnysilva.com/cardiac-troponin/images/2041_341_142.jpg" type="image/jpeg" height="190" width="393" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 16:54:27 GMT</pubDate>
</item>
<item>
 <title>Info Hus CardiacTroponin</title>
 <description>PCI with normal post-PCI CK level n 1128 Death, CABG, repeat PCI, cardiac admissions Higher 1-yr event rate with TnI elevation TnI gt 5 times ULN an independent predictor of in-hospital but not 1-yr events TnI post-PCI not predictive of mortality&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QkOqTpYx7Lo:l4DSmcudCvI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QkOqTpYx7Lo:l4DSmcudCvI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=QkOqTpYx7Lo:l4DSmcudCvI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QkOqTpYx7Lo:l4DSmcudCvI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=QkOqTpYx7Lo:l4DSmcudCvI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QkOqTpYx7Lo:l4DSmcudCvI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CardiacTroponin</category>
 <link>http://www.johnnysilva.com/cardiac-troponin/info-hus.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cardiac-troponin/info-hus.html</guid>
 <pubDate>Wed, 22 Feb 2012 16:36:59 GMT</pubDate>
</item>
<item>
 <title>Tests For Liver Function TestMethodology</title>
 <description>The clinical laboratory offers several tests for the assessment of liver function. The enzymes alkaline phosphatase, ALT, AST, GGT, and 5'-nucleotidase are helpful in the assessment of the proper functioning and inflammatory status of the liver. Because the liver is the site for metabolism of carbohydrate, protein, and lipids, as well as for the synthesis of many proteins, the conjugation of bilirubin, and detoxification of drugs and other substances, the liver may be assessed by measurement of...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=o_qDZz2ZYho:01IYzbNvjF4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=o_qDZz2ZYho:01IYzbNvjF4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=o_qDZz2ZYho:01IYzbNvjF4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=o_qDZz2ZYho:01IYzbNvjF4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=o_qDZz2ZYho:01IYzbNvjF4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=o_qDZz2ZYho:01IYzbNvjF4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TestMethodology</category>
 <link>http://www.johnnysilva.com/test-methodology/tests-for-liver-function.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/test-methodology/tests-for-liver-function.html</guid>
 <pubDate>Wed, 22 Feb 2012 15:58:34 GMT</pubDate>
</item>
<item>
 <title>Introduction of Monoclonal Antibodies Into Clinical Practice ChronicLymphocytic</title>
 <description>Several problems have limited the successful introduction of monoclonal antibody therapies into clinical practice. These obstacles include 1 identification of tumor-specific antigens, 2 antigen surface density, 3 antibody production, 4 internalization of antigen or antigen-antibody complex, 5 antigenicity of the antibody resulting in host sensitization, 6 infusion toxicity from host humoral response, and 7 delivery of antibody to bulky tumors. An ideal antigen should be expressed at relatively...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=h1Oe2BGSh_4:mWoFB8Bx0f4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=h1Oe2BGSh_4:mWoFB8Bx0f4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=h1Oe2BGSh_4:mWoFB8Bx0f4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=h1Oe2BGSh_4:mWoFB8Bx0f4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=h1Oe2BGSh_4:mWoFB8Bx0f4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=h1Oe2BGSh_4:mWoFB8Bx0f4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ChronicLymphocytic</category>
 <link>http://www.johnnysilva.com/chronic-lymphocytic/introduction-of-monoclonal-antibodies-into-clinical-practice.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/chronic-lymphocytic/introduction-of-monoclonal-antibodies-into-clinical-practice.html</guid>
 <pubDate>Wed, 22 Feb 2012 15:56:26 GMT</pubDate>
</item>
<item>
 <title>Structure motifs of RNA Molecular Biology 2</title>
 <description>RNA motifs refer to the small, finite and naturally occurring structural elements of RNAs that are present abundantly as non-canonical bps in hairpins loops loop motifs and sequences involved in tertiary interactions tertiary motifs . The most important secondary structural element in RNA is the A-form double helix A-helix . However, motifs, which differ from A-helix, are discrete and their conformations are altered if residues are added or deleted from them. Some recognizable motifs found in...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2SFmY0d97jw:wgMDCQfHBzM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2SFmY0d97jw:wgMDCQfHBzM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=2SFmY0d97jw:wgMDCQfHBzM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2SFmY0d97jw:wgMDCQfHBzM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=2SFmY0d97jw:wgMDCQfHBzM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2SFmY0d97jw:wgMDCQfHBzM:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <link>http://www.johnnysilva.com/molecular-biology-2/structure-motifs-of-rna.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/molecular-biology-2/structure-motifs-of-rna.html</guid>
 <pubDate>Wed, 22 Feb 2012 15:37:51 GMT</pubDate>
</item>
<item>
 <title>Info Vag RheumatoidArthritis</title>
 <description>11.4. Inspection 4 General bone thickening Extensive thickening of bone is characteristic of Paget's disease and longstanding osteitis. In the latter case there are usually other signs, such as scarring or sinuses. 11.5. Inspection 5 Tibial shape Note any abnormal anterior curvature tibial kyphosis , possibly secondary to Paget's disease, malunited fracture, syphilis or rickets. Rickets affects the distal half of both tibia and fibula, and there are associated lateral and torsional deformities....&lt;p&gt;&lt;a href="http://www.johnnysilva.com/rheumatoid-arthritis/info-vag.html"&gt;&lt;img src="http://www.johnnysilva.com/rheumatoid-arthritis/images/2132_51_717-osteitis-tibial-syphilis.jpg" style="width: 367pt; height: 191pt;" alt="Osteitis Tibial Syphilis"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4DqHcpjmt84:t3ZZjrzMAhc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4DqHcpjmt84:t3ZZjrzMAhc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=4DqHcpjmt84:t3ZZjrzMAhc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4DqHcpjmt84:t3ZZjrzMAhc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=4DqHcpjmt84:t3ZZjrzMAhc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4DqHcpjmt84:t3ZZjrzMAhc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>RheumatoidArthritis</category>
 <link>http://www.johnnysilva.com/rheumatoid-arthritis/info-vag.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/rheumatoid-arthritis/info-vag.html</guid>
 <media:content url="http://www.johnnysilva.com/rheumatoid-arthritis/images/2132_51_717-osteitis-tibial-syphilis.jpg" type="image/jpeg" height="267" width="514" />
 <media:title>Osteitis Tibial Syphilis</media:title>
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 15:02:45 GMT</pubDate>
</item>
<item>
 <title>DNA Templates for dsRNA Production CaenorhabditisElegans</title>
 <description>1. For cloning gene fragments into plasmid-based templates choose a vector with the appropriate bacteriophage promoter sites Fig. 1, Constructs 1-4,6 and appropriately placed restriction sites. Plasmid vectors are available from several suppliers of molecular biology products. pBlueScript Stratagene has T3 and T7 promoter sites that could be used for Constructs 1, 3-6. A double T7 plasmid L4440, generated by the Fire Lab 3 , Fig. 1, Construct 2 and Fig. 2 is used in the feeding protocol and is...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OUTzvr-BaV0:lbUbYOS5TOA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OUTzvr-BaV0:lbUbYOS5TOA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=OUTzvr-BaV0:lbUbYOS5TOA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OUTzvr-BaV0:lbUbYOS5TOA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=OUTzvr-BaV0:lbUbYOS5TOA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OUTzvr-BaV0:lbUbYOS5TOA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CaenorhabditisElegans</category>
 <link>http://www.johnnysilva.com/caenorhabditis-elegans/dna-templates-for-dsrna-production.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/caenorhabditis-elegans/dna-templates-for-dsrna-production.html</guid>
 <pubDate>Wed, 22 Feb 2012 15:01:12 GMT</pubDate>
</item>
<item>
 <title>References For Boxes 15 1 And 152 PeriodontalDisease</title>
 <description>I biko V. Ilayakawa M. Mural s. i-t al ilycylpropvl dipeptidyl amino-peptidase trom liactcnmles gingi iili . I Clin Periodontal 1985 04 106 2. donogianaki I , Vtooney J, Kinane IM Ihe ability ol acute gingival crevicular lluid phase proteins to distinguish gingivitis and periodontitis sitt-s. I lin Periodontol 1992 19 08. V Iking I, imasoni Ci. Held Beta glucuronidase correlated with inflammation in the exudate from human gingiva. rch Oral Biol 1970 15 45 -I Kcighton l gt . Radford R, Nay lor...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u8irjNIZVK0:MJ_8zfi-vG8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u8irjNIZVK0:MJ_8zfi-vG8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=u8irjNIZVK0:MJ_8zfi-vG8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u8irjNIZVK0:MJ_8zfi-vG8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=u8irjNIZVK0:MJ_8zfi-vG8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u8irjNIZVK0:MJ_8zfi-vG8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PeriodontalDisease</category>
 <link>http://www.johnnysilva.com/periodontal-disease/references-for-boxes-15-1-and-152.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/periodontal-disease/references-for-boxes-15-1-and-152.html</guid>
 <pubDate>Wed, 22 Feb 2012 14:35:50 GMT</pubDate>
</item>
<item>
 <title>Carbon Nanotubes BiomedicalNanotechnology</title>
 <description>For a detailed discussion on the properties, growth and applications of carbon nanotubes, the reader is referred to 1 here, only a brief overview is provided. A carbon nanotube is an elongated fullerene molecule with diameter as small as 7 A. Configura-tionally, a nanotube is equivalent to a sheet of graphite rolled into a tube. The resulting single-walled carbon nanotube SWCNT is denoted by its chiral vector n, m where n and m are indices in the graphene sheet lattice vector. When n-m 3 is an...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=SWqYb9HmlNE:Ven6tHqiTu8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=SWqYb9HmlNE:Ven6tHqiTu8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=SWqYb9HmlNE:Ven6tHqiTu8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=SWqYb9HmlNE:Ven6tHqiTu8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=SWqYb9HmlNE:Ven6tHqiTu8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=SWqYb9HmlNE:Ven6tHqiTu8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BiomedicalNanotechnology</category>
 <link>http://www.johnnysilva.com/biomedical-nanotechnology/carbon-nanotubes.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/biomedical-nanotechnology/carbon-nanotubes.html</guid>
 <pubDate>Wed, 22 Feb 2012 14:34:24 GMT</pubDate>
</item>
<item>
 <title>Info Kly BoneDensity</title>
 <description>The second edition of Dr. Sydney Lou Bonnick's text Bone Densitometry in Clinical Practice is an expansion of her highly regarded first edition, which has provided the bone densitometry community with simply the best, most accurate, and most precisely written resource in our field. Dr. Bonnick has applied her very careful and exact scientific approaches to expand and improve on her widely regarded initial text. In addition to the chapters in the first edition on the science of bone densitometry...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=RRiahkIpYsQ:emJMBTJT4LQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=RRiahkIpYsQ:emJMBTJT4LQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=RRiahkIpYsQ:emJMBTJT4LQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=RRiahkIpYsQ:emJMBTJT4LQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=RRiahkIpYsQ:emJMBTJT4LQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=RRiahkIpYsQ:emJMBTJT4LQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BoneDensity</category>
 <link>http://www.johnnysilva.com/bone-density/info-kly.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/bone-density/info-kly.html</guid>
 <pubDate>Wed, 22 Feb 2012 14:23:02 GMT</pubDate>
</item>
<item>
 <title>Info Dwp ParticleTracking</title>
 <description>Detailed explanation of polymerization with NHS-acrylate is as follows Fig. 6 acrylamide and bis-acrylamide solutions are degassed in a vacuum chamber for 15 min. NHS-acrylate is dissolved in toluene 2 , w v . To polymerize the solution, 1.5-ml TEMED and 5 ml of 10 ammonium persulfate are added to the degassed solution with the appropriate amount of 50-mM HEPES pH 8.2 to yield a final volume of 500 ml. A fixed volume of 60 ml of the mixture is immediately pipetted onto the center of the...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/particle-tracking/info-dwp.html"&gt;&lt;img src="http://www.johnnysilva.com/particle-tracking/images/2063_17_19.jpg" style="width: 164pt; height: 90pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=aqtSivb32I8:KqlyQbtVS2I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=aqtSivb32I8:KqlyQbtVS2I:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=aqtSivb32I8:KqlyQbtVS2I:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=aqtSivb32I8:KqlyQbtVS2I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=aqtSivb32I8:KqlyQbtVS2I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=aqtSivb32I8:KqlyQbtVS2I:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ParticleTracking</category>
 <link>http://www.johnnysilva.com/particle-tracking/info-dwp.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/particle-tracking/info-dwp.html</guid>
 <media:content url="http://www.johnnysilva.com/particle-tracking/images/2063_17_19.jpg" type="image/jpeg" height="126" width="230" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 13:55:34 GMT</pubDate>
</item>
<item>
 <title>Suggested References 1 BioanalyticalChemistry</title>
 <description>O. Zaborsky, Immobilized Enzymes, CRC Press, Cleveland, OH, 1973. L. B. Wingard, Jr., E. Katchalski-Katzir, and L. Goldstein, Eds., Applied Biochemistry and Bioengineering, Volume 1 Immobilized Enzyme Principles, Academic Press, New York, 1976. L. B. Wingard, Jr., E. Katchalski-Katzir, and L. Goldstein, Eds., Applied Biochemistry and Bioengineering, Volume 3 Analytical Applications of Immobilized Enzymes and Cells, Academic Press, New York, 1981. P. W. CarrandL. D. Bowers, Chemical Analysis,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=M4AG_m4kk9M:QpBxLZ5q6qI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=M4AG_m4kk9M:QpBxLZ5q6qI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=M4AG_m4kk9M:QpBxLZ5q6qI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=M4AG_m4kk9M:QpBxLZ5q6qI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=M4AG_m4kk9M:QpBxLZ5q6qI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=M4AG_m4kk9M:QpBxLZ5q6qI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BioanalyticalChemistry</category>
 <link>http://www.johnnysilva.com/bioanalytical-chemistry/suggested-references-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/bioanalytical-chemistry/suggested-references-1.html</guid>
 <pubDate>Wed, 22 Feb 2012 13:42:38 GMT</pubDate>
</item>
<item>
 <title>Other Infradian Rhythms CircadianRhythms</title>
 <description>A curious infradian rhythm that does not fit into any of the categories discussed in the previous section involves the Canadian lynx Lynx canadensis and the Arctic hare Lepus arcticus , both shown in Figure 4.34. The lynx is hunted commercially for its fur, and good records of fur returns have been kept since the early 1800s. As shown in Figure 4.35, fur returns exhibit a remarkably regular 10-year rhythm. The cause of the rhythm is not fully known, but it is related to a rhythm in the size of...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/circadian-rhythms/other-infradian-rhythms.html"&gt;&lt;img src="http://www.johnnysilva.com/circadian-rhythms/images/2113_148_178.jpg" style="width: 367pt; height: 119pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TwQlWRUppKM:8k6Lo-KrWz0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TwQlWRUppKM:8k6Lo-KrWz0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=TwQlWRUppKM:8k6Lo-KrWz0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TwQlWRUppKM:8k6Lo-KrWz0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=TwQlWRUppKM:8k6Lo-KrWz0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TwQlWRUppKM:8k6Lo-KrWz0:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CircadianRhythms</category>
 <link>http://www.johnnysilva.com/circadian-rhythms/other-infradian-rhythms.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/circadian-rhythms/other-infradian-rhythms.html</guid>
 <media:content url="http://www.johnnysilva.com/circadian-rhythms/images/2113_148_178.jpg" type="image/jpeg" height="167" width="514" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 12:35:23 GMT</pubDate>
</item>
<item>
 <title>Control of food contact materials in the EU ContactMaterials</title>
 <description>The basic rule in the Community food legislation specifies that only safe food shall be placed on the market General Food Law14 Art. 14 . Consequently food contact materials shall not transfer their substance into the food in concentrations that can endanger human health Art. 3 Framework Regulation . The main players to ensure safety as regards food contact materials are the packaging industry, the food industry, competent authorities in the Member States, and the European Commission. 3.6.1 The...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YjRZJdg07nI:et6VTn9ZyNA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YjRZJdg07nI:et6VTn9ZyNA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=YjRZJdg07nI:et6VTn9ZyNA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YjRZJdg07nI:et6VTn9ZyNA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=YjRZJdg07nI:et6VTn9ZyNA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YjRZJdg07nI:et6VTn9ZyNA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ContactMaterials</category>
 <link>http://www.johnnysilva.com/contact-materials/control-of-food-contact-materials-in-the-eu.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/contact-materials/control-of-food-contact-materials-in-the-eu.html</guid>
 <pubDate>Wed, 22 Feb 2012 11:58:36 GMT</pubDate>
</item>
<item>
 <title>Cinnamon And Mydriasis StructureActivity</title>
 <description>Table 3.2 Derivatives of Solanaceous Alkaloids and Their Advantage, if any, of Molecular Modification Ipratropiumb bromide Atropine N-oxide hydrochloride Hyoscyamine hydrobromide Methylatropine nitrate Scopolamine hydrobromide hydrobromide Methscopolamine bromide NF bromide NF Anisotropine methylbromidec 0.5 mg orali.v or s.c. 0.5-1.0 ophthalmic solution 2.5-5.0 mg oral 0.251.0 mg s.c. or i.m. 2-4 mg oral 0.25-0.5 mg s.c. or release of the alkaloid Low systemic absorption Slow release of the...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=j4x1RDgwRP4:cTkM4Y3JOeQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=j4x1RDgwRP4:cTkM4Y3JOeQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=j4x1RDgwRP4:cTkM4Y3JOeQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=j4x1RDgwRP4:cTkM4Y3JOeQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=j4x1RDgwRP4:cTkM4Y3JOeQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=j4x1RDgwRP4:cTkM4Y3JOeQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>StructureActivity</category>
 <link>http://www.johnnysilva.com/structure-activity/m5-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/structure-activity/m5-1.html</guid>
 <pubDate>Wed, 22 Feb 2012 10:56:47 GMT</pubDate>
</item>
<item>
 <title>Structures Of The Cardiac Cytoskeleton Cell Adhesion And The Sarcomere GeneTherapy</title>
 <description>The major function of cardiomyocytes is in the cardiac contraction-relaxation cycle. The contractile proteins in cardiomyocytes constitute about 75 of the total volume of the myocardium, although only about one-third of the number of all the cells in the myocardium are cardiomyocytes. About half of each ventricular cell is occupied by myofibers, and about one-fourth to one-third by mitochondria. The major proteins involved in contraction and relaxation are the thin filament composed of actin,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TZHtN6oF78U:O_4W8UR0D0M:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TZHtN6oF78U:O_4W8UR0D0M:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=TZHtN6oF78U:O_4W8UR0D0M:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TZHtN6oF78U:O_4W8UR0D0M:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=TZHtN6oF78U:O_4W8UR0D0M:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=TZHtN6oF78U:O_4W8UR0D0M:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>GeneTherapy</category>
 <link>http://www.johnnysilva.com/gene-therapy/structures-of-the-cardiac-cytoskeleton-cell-adhesion-and-the-sarcomere.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/gene-therapy/structures-of-the-cardiac-cytoskeleton-cell-adhesion-and-the-sarcomere.html</guid>
 <pubDate>Wed, 22 Feb 2012 10:10:10 GMT</pubDate>
</item>
<item>
 <title>C Ritical Developments In Biochemistry 1 AminoAcids</title>
 <description>Thermodynamics of the Folding Process in Globular Proteins Section 6.1 considered the noncovalent binding energies that stabilize a protein structure. However, the folding of a protein depends ultimately on the difference in Gibbs free energy AG between the folded F and unfolded U states at some temperature T AG Gp - GU AH - TAS Hf - Hu - T Sf - SU In the unfolded state, the peptide chain and its R groups interact with solvent water, and any measurement of the free energy change upon folding...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/amino-acids/c-ritical-developments-in-biochemistry-1.html"&gt;&lt;img src="http://www.johnnysilva.com/amino-acids/images/1924_221_219.jpg" style="width: 72pt; height: 63pt;" title="FIGURE model for the steps involved the folding globular proteins Chaperone proteins may assist the initiation the folding process"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=CNJghbMdr9o:zRCxyBxEtgU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=CNJghbMdr9o:zRCxyBxEtgU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=CNJghbMdr9o:zRCxyBxEtgU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=CNJghbMdr9o:zRCxyBxEtgU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=CNJghbMdr9o:zRCxyBxEtgU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=CNJghbMdr9o:zRCxyBxEtgU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>AminoAcids</category>
 <link>http://www.johnnysilva.com/amino-acids/c-ritical-developments-in-biochemistry-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/amino-acids/c-ritical-developments-in-biochemistry-1.html</guid>
 <media:content url="http://www.johnnysilva.com/amino-acids/images/1924_221_219.jpg" type="image/jpeg" height="88" width="101" />
 <media:title />
 <media:description type="html">FIGURE model for the steps involved the folding globular proteins Chaperone proteins may assist the initiation the folding process</media:description>
 <pubDate>Wed, 22 Feb 2012 10:06:19 GMT</pubDate>
</item>
<item>
 <title>Benefits Of Orthodontics For A Periodontal Patient PeriodontalDisease</title>
 <description>Orthodontic therapy can provide several benefits to the adult periodontal patient. I he following six factors should be considered 1. Aligning crowded or malposed maxillary or mandibular anterior teeth permits the adult patient better access to adequately clean .ill surfaces ol their teeth. This could be a tremendous advantage for patients who are susceptible to periodontal bone loss or do not have the dexterity to adequately maintain their oral hygiene. 2. Vertical orthodontic tooth...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LMpool-kB_A:MtlhNola0kk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LMpool-kB_A:MtlhNola0kk:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LMpool-kB_A:MtlhNola0kk:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LMpool-kB_A:MtlhNola0kk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LMpool-kB_A:MtlhNola0kk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LMpool-kB_A:MtlhNola0kk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PeriodontalDisease</category>
 <link>http://www.johnnysilva.com/periodontal-disease/benefits-of-orthodontics-for-a-periodontal-patient.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/periodontal-disease/benefits-of-orthodontics-for-a-periodontal-patient.html</guid>
 <pubDate>Wed, 22 Feb 2012 09:15:42 GMT</pubDate>
</item>
<item>
 <title>Abc Ipz PeriodontalDisease</title>
 <description>Fig. 41-34 Implacare implant instruments. These implant instruments from the Hu-Friedy Company have autoclavable stainless steel handles and three different cone socket plastic tip designs. A, I he Columbia 4R-4L curette tip B, The H6-H7 sickle scaler tip, C, he 204S sickle scaler tip 578 PARI 5 l'rattment of l'eruhionttil Lfisi'tisc Fig. 41-36 Chisel scaler and file scaler. Ficj. 41-38 Piezoelectric ultrasonic unit. Pie on Master 400. Cour tesy EMS Electromedical Systems, Dallas, TX. Fig....&lt;p&gt;&lt;a href="http://www.johnnysilva.com/periodontal-disease/abc-ipz.html"&gt;&lt;img src="http://www.johnnysilva.com/periodontal-disease/images/2051_459_617.jpg" style="width: 259pt; height: 167pt;" title="Fig Magnetostriclive ultrasonic unit The Cavitron SPS ultrasonic scaler Courtesy Dcnlsply International Inc York "/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YA-0Bqc7M4U:bEtkcaEBLZs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YA-0Bqc7M4U:bEtkcaEBLZs:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=YA-0Bqc7M4U:bEtkcaEBLZs:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YA-0Bqc7M4U:bEtkcaEBLZs:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=YA-0Bqc7M4U:bEtkcaEBLZs:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YA-0Bqc7M4U:bEtkcaEBLZs:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PeriodontalDisease</category>
 <link>http://www.johnnysilva.com/periodontal-disease/abc-ipz.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/periodontal-disease/abc-ipz.html</guid>
 <media:content url="http://www.johnnysilva.com/periodontal-disease/images/2051_459_617.jpg" type="image/jpeg" height="234" width="363" />
 <media:title />
 <media:description type="html">Fig Magnetostriclive ultrasonic unit The Cavitron SPS ultrasonic scaler Courtesy Dcnlsply International Inc York </media:description>
 <pubDate>Wed, 22 Feb 2012 09:13:20 GMT</pubDate>
</item>
<item>
 <title>Transient Expression MammalianCells</title>
 <description>In transient expression systems or ''transient transfections,'' DNA is introduced into the cell and maintained replicated as an extrachromasomal unit. Besides the strength of the promoter driving expression of the product gene, transfection efficiency percentage of cells taking-up and expressing DNA is the most important factor in determining the overall expression level, and several methods have been recently developed which yield reproducibly high transfection efficiencies 50 , see following...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=syDaO8Ay134:te9_e2li0yg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=syDaO8Ay134:te9_e2li0yg:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=syDaO8Ay134:te9_e2li0yg:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=syDaO8Ay134:te9_e2li0yg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=syDaO8Ay134:te9_e2li0yg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=syDaO8Ay134:te9_e2li0yg:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>MammalianCells</category>
 <link>http://www.johnnysilva.com/mammalian-cells/transient-expression.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/mammalian-cells/transient-expression.html</guid>
 <pubDate>Wed, 22 Feb 2012 06:12:08 GMT</pubDate>
</item>
<item>
 <title>Centriole Duplication BasalBodies</title>
 <description>Centriole duplication is first seen at the beginning of S phase or during S phase by the appearance of short daughter centrioles, or pro-centrioles, at right angles to and separated slightly from the two parental centrioles at their proximal ends Figure 9.1c 14, 15, 17-19 . These pro-centrioles elongate during S and G2, reaching mature length in mitosis or the following G 14, 20 . Daughter centrioles the elongating pro-centrioles do not acquire distal and subdistal appendages until they fully...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dffUk7Ql5rY:o2ildrfbuU4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dffUk7Ql5rY:o2ildrfbuU4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=dffUk7Ql5rY:o2ildrfbuU4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dffUk7Ql5rY:o2ildrfbuU4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=dffUk7Ql5rY:o2ildrfbuU4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dffUk7Ql5rY:o2ildrfbuU4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BasalBodies</category>
 <link>http://www.johnnysilva.com/basal-bodies/centriole-duplication.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/basal-bodies/centriole-duplication.html</guid>
 <pubDate>Wed, 22 Feb 2012 04:37:50 GMT</pubDate>
</item>
<item>
 <title>Prolongation Of Drug Action AdverseEffects</title>
 <description>A larger dose is the most obvious way to prolong a drug action. As this is not always feasible, other mechanisms are used. Vasoconstriction will reduce local blood flow so that distribution of drug away from an injection site is retarded, e.g. local anaesthetic action is prolonged by combination with adrenaline epinephrine . Slowing of metabolism may usefully extend drug action, as when a dopa decarboxylase inhibitor, e.g. carbidopa, is combined with levodopa as co-careldopa for parkinsonism....&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wDEbjZrsznU:Oiiyyr766zM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wDEbjZrsznU:Oiiyyr766zM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=wDEbjZrsznU:Oiiyyr766zM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wDEbjZrsznU:Oiiyyr766zM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=wDEbjZrsznU:Oiiyyr766zM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wDEbjZrsznU:Oiiyyr766zM:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>AdverseEffects</category>
 <link>http://www.johnnysilva.com/adverse-effects/prolongation-of-drug-action.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/adverse-effects/prolongation-of-drug-action.html</guid>
 <pubDate>Wed, 22 Feb 2012 04:31:59 GMT</pubDate>
</item>
<item>
 <title>Treatment KienbockDisease</title>
 <description>The combination of unknown etiology and unknown natural history has led to a large, and sometimes baffling, array of surgical procedures that are difficult to compare. Because of the many surgical options, the authors will first discuss the different procedures based on their underlying principles in regard to how they attempt to remedy the pathogenesis of the disease. Then we will discuss our approach to treatment of patients who have Kienbock's disease. Surgical treatment strategies fall into...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/kienbock-disease/treatment.html"&gt;&lt;img src="http://www.johnnysilva.com/kienbock-disease/images/2050_57_72-kienbock-disease-stage.jpg" style="width: 276pt; height: 400pt;" alt="Kienbock Disease Stage"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=nePdSHkjORo:fyLO4sDiOlQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=nePdSHkjORo:fyLO4sDiOlQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=nePdSHkjORo:fyLO4sDiOlQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=nePdSHkjORo:fyLO4sDiOlQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=nePdSHkjORo:fyLO4sDiOlQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=nePdSHkjORo:fyLO4sDiOlQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>KienbockDisease</category>
 <link>http://www.johnnysilva.com/kienbock-disease/treatment.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/kienbock-disease/treatment.html</guid>
 <media:content url="http://www.johnnysilva.com/kienbock-disease/images/2050_57_72-kienbock-disease-stage.jpg" type="image/jpeg" height="560" width="386" />
 <media:title>Kienbock Disease Stage</media:title>
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 04:15:47 GMT</pubDate>
</item>
<item>
 <title>Info Wdz NerveAgents</title>
 <description>doses .39,40,153 161 Soman at doses of 1.0 and 1.2 mg kg inhibited spinal cord NTE 67 and 37 of control, respectively in hens protected with the antidote, atropine.161 Tabun at a dose of 12 mg kg decreased NTE activity 67 of control in the spinal cord of protected hens.161 The inhibition of NTE activity in these studies were below threshold levels and suggested the inability of soman and tabun to cause OPIDN. Rats exposed to low-dose sarin 300 g kg, p.o. for 90 days significantly inhibited...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=b0uBIet4J-c:L459wMhJK2I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=b0uBIet4J-c:L459wMhJK2I:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=b0uBIet4J-c:L459wMhJK2I:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=b0uBIet4J-c:L459wMhJK2I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=b0uBIet4J-c:L459wMhJK2I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=b0uBIet4J-c:L459wMhJK2I:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>NerveAgents</category>
 <link>http://www.johnnysilva.com/nerve-agents/info-wdz.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/nerve-agents/info-wdz.html</guid>
 <pubDate>Wed, 22 Feb 2012 04:01:28 GMT</pubDate>
</item>
<item>
 <title>Iii Genetics Of Bloom Syndrome LifeSpan</title>
 <description>Characterization of the genetics of BS as well as its natural history has been facilitated by the accession in and regular follow-up of persons with the syndrome through the Bloom's Syndrome Registry 29 . This registry is a cohort of nearly all persons in the world diagnosed with BS from its identification as a clinical entity as reported in 1954 until 1991 when the Registry was closed arbitrarily to new accessions. The Registry contains 168 persons representing all but one of the major...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/life-span/iii-genetics-of-bloom-syndrome.html"&gt;&lt;img src="http://www.johnnysilva.com/life-span/images/2105_112_24.png" style="width: 367pt; height: 136pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=eE5zWnL7Y60:YAC2s73fvQ4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=eE5zWnL7Y60:YAC2s73fvQ4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=eE5zWnL7Y60:YAC2s73fvQ4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=eE5zWnL7Y60:YAC2s73fvQ4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=eE5zWnL7Y60:YAC2s73fvQ4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=eE5zWnL7Y60:YAC2s73fvQ4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>LifeSpan</category>
 <link>http://www.johnnysilva.com/life-span/iii-genetics-of-bloom-syndrome.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/life-span/iii-genetics-of-bloom-syndrome.html</guid>
 <media:content url="http://www.johnnysilva.com/life-span/images/2105_112_24.png" type="image/png" height="190" width="514" />
 <media:title />
 <media:description type="html" />
 <pubDate>Wed, 22 Feb 2012 03:40:58 GMT</pubDate>
</item>
<item>
 <title>Calretinin Expression In Cell Proliferation And Differentiation CalciumBinding</title>
 <description>The relationship between calretinin expression and cell proliferation and the state of differentiation also has been reported in nonneuronal cell types. Indeed, studies of several tumour cell lines have provided evidence supporting such a relationship. Gotzos et al. 1996a found that 8 of 10 colonic carcinoma cell lines expressed calretinin, and the protein was found in rapidly proliferating cells. Upon being induced to differentiate by treatment with sodium butyrate and hexamethylene...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LCCpGIWDA80:biNWu9tHmAc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LCCpGIWDA80:biNWu9tHmAc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LCCpGIWDA80:biNWu9tHmAc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LCCpGIWDA80:biNWu9tHmAc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LCCpGIWDA80:biNWu9tHmAc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LCCpGIWDA80:biNWu9tHmAc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CalciumBinding</category>
 <link>http://www.johnnysilva.com/calcium-binding/calretinin-expression-in-cell-proliferation-and-differentiation.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/calcium-binding/calretinin-expression-in-cell-proliferation-and-differentiation.html</guid>
 <pubDate>Wed, 22 Feb 2012 02:07:09 GMT</pubDate>
</item>
<item>
 <title>Structure Dqb ClinicalFeatures</title>
 <description>A stratified squamous epithelium lines the vagina and the vaginal cervix it contains no glands and is lubricated partly by cervical mucus and partly by desquamated vaginal epithelial cells. In nulliparous women the vaginal wall is rugose, but it becomes smoother after childbirth. The rugae of the Fig. 102 Coronal section of the uterus and vagina. Note the important relationships of ureter and uterine artery. Fig. 102 Coronal section of the uterus and vagina. Note the important relationships of...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/clinical-features/structure-dqb.html"&gt;&lt;img src="http://www.johnnysilva.com/clinical-features/images/2117_129_125-vagina-rugous.jpg" style="width: 306pt; height: 247pt;" title="Fig 102 Coronal section the uterus and vagina Note the important relationships ureter and uterine artery" alt="Vagina Rugous"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spJfmJ8eBNE:gPFCVvzGVeI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spJfmJ8eBNE:gPFCVvzGVeI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=spJfmJ8eBNE:gPFCVvzGVeI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spJfmJ8eBNE:gPFCVvzGVeI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=spJfmJ8eBNE:gPFCVvzGVeI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=spJfmJ8eBNE:gPFCVvzGVeI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ClinicalFeatures</category>
 <link>http://www.johnnysilva.com/clinical-features/structure-dqb.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/clinical-features/structure-dqb.html</guid>
 <media:content url="http://www.johnnysilva.com/clinical-features/images/2117_129_125-vagina-rugous.jpg" type="image/jpeg" height="346" width="428" />
 <media:title>Vagina Rugous</media:title>
 <media:description type="html">Fig 102 Coronal section the uterus and vagina Note the important relationships ureter and uterine artery</media:description>
 <pubDate>Wed, 22 Feb 2012 01:20:22 GMT</pubDate>
</item>
<item>
 <title>Treatment of Tachycardias with Temporary Pacing VentricularPacing</title>
 <description>Temporary cardiac pacing has been used for the termination and or prevention of a variety of arrhythmias. Pacing-termination of ventricular tachycardia is discussed in detail in Chapter 8 on the implantable cardioverter defibrillator and will not be dealt with here. Type I atrial flutter can be successfully pace-terminated approximately 65 of the time in an unselected population and in over 90 of patients in whom atrial flutter develops after surgery.58 Due to the development of radiofrequency...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Di7fC5O78is:mJLUVSQ60IE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Di7fC5O78is:mJLUVSQ60IE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Di7fC5O78is:mJLUVSQ60IE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Di7fC5O78is:mJLUVSQ60IE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Di7fC5O78is:mJLUVSQ60IE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Di7fC5O78is:mJLUVSQ60IE:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>VentricularPacing</category>
 <link>http://www.johnnysilva.com/ventricular-pacing/treatment-of-tachycardias-with-temporary-pacing.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/ventricular-pacing/treatment-of-tachycardias-with-temporary-pacing.html</guid>
 <pubDate>Wed, 22 Feb 2012 00:46:53 GMT</pubDate>
</item>
<item>
 <title>Concluding Remarks MagneticNanoparticles</title>
 <description>Almost 40 years ago initial concepts of gene therapy have been conceived 3 . The validity of the concept and therapeutic efficacy has been demonstrated in humans using viral vectors 247 . However, this success has been overshadowed by severe adverse events 248 . This and another tragic setback to nucleic acid therapy concepts, the death of a treated patient 249 , highlight how little we understand the complex biology being the basis of the therapeutic concept we pursue. Despite more than 30...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/magnetic-nanoparticles/concluding-remarks.html"&gt;&lt;img src="http://www.johnnysilva.com/magnetic-nanoparticles/images/1965_30_26.jpg" style="width: 212pt; height: 135pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FFVWrszfX8g:qqfp_7JrWAU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FFVWrszfX8g:qqfp_7JrWAU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=FFVWrszfX8g:qqfp_7JrWAU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FFVWrszfX8g:qqfp_7JrWAU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=FFVWrszfX8g:qqfp_7JrWAU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FFVWrszfX8g:qqfp_7JrWAU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>MagneticNanoparticles</category>
 <link>http://www.johnnysilva.com/magnetic-nanoparticles/concluding-remarks.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/magnetic-nanoparticles/concluding-remarks.html</guid>
 <media:content url="http://www.johnnysilva.com/magnetic-nanoparticles/images/1965_30_26.jpg" type="image/jpeg" height="189" width="297" />
 <media:title />
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 22:59:15 GMT</pubDate>
</item>
<item>
 <title>History 1 Physical Examination 2</title>
 <description>As in all areas of medicine, the history of the presenting illness will guide the diagnostic work-up. In the history of a patient with musculoskeletal complaints, important information to gather includes whether the primary symptom is pain, limited movement, weakness, instability, or a combination of symptoms. The onset of the symptoms whether acute, chronic, or an acute worsening of a chronic problem can be significant. The location, severity, and pattern of radiation of pain should be...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=EdwunQ4PZKI:peBvibQz47M:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=EdwunQ4PZKI:peBvibQz47M:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=EdwunQ4PZKI:peBvibQz47M:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=EdwunQ4PZKI:peBvibQz47M:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=EdwunQ4PZKI:peBvibQz47M:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=EdwunQ4PZKI:peBvibQz47M:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <link>http://www.johnnysilva.com/physical-examination-2/history-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/physical-examination-2/history-1.html</guid>
 <pubDate>Tue, 21 Feb 2012 22:55:23 GMT</pubDate>
</item>
<item>
 <title>Stress Myocardial Perfusion Imaging CardiacRehabilitation</title>
 <description>Exercise perfusion imaging appears to be superior to exercise ECG alone in detecting CAD, in identifying multivessel disease, in localizing diseased vessels, and in determining the extent of ischemic and infarcted myocardium. Perfusion imaging is also useful for detecting myocardial viability in patients with left ventricular dysfunction, either regional or global, with or without Q waves, and provides important information with regard to risk stratification and therapeutic strategies.6 Stress...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=R15BrgVa2I8:5-dFMd00aIY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=R15BrgVa2I8:5-dFMd00aIY:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=R15BrgVa2I8:5-dFMd00aIY:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=R15BrgVa2I8:5-dFMd00aIY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=R15BrgVa2I8:5-dFMd00aIY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=R15BrgVa2I8:5-dFMd00aIY:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CardiacRehabilitation</category>
 <link>http://www.johnnysilva.com/cardiac-rehabilitation/stress-myocardial-perfusion-imaging.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cardiac-rehabilitation/stress-myocardial-perfusion-imaging.html</guid>
 <pubDate>Tue, 21 Feb 2012 21:59:47 GMT</pubDate>
</item>
<item>
 <title>Edward D Zanders PhD ChemicalGenomics</title>
 <description>2005 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. Methods in Molecular Biology is a trademark of The Humana Press Inc. All papers, comments, opinions, conclusions, or recommendations are those of the author s ,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=rHTfCzsTbAA:Yy83sdOMNjU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=rHTfCzsTbAA:Yy83sdOMNjU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=rHTfCzsTbAA:Yy83sdOMNjU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=rHTfCzsTbAA:Yy83sdOMNjU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=rHTfCzsTbAA:Yy83sdOMNjU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=rHTfCzsTbAA:Yy83sdOMNjU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ChemicalGenomics</category>
 <link>http://www.johnnysilva.com/chemical-genomics/edward-d-zanders-phd.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/chemical-genomics/edward-d-zanders-phd.html</guid>
 <pubDate>Tue, 21 Feb 2012 21:38:59 GMT</pubDate>
</item>
<item>
 <title>CarbarnateDerived Inhibitors StructureActivity</title>
 <description>The prototype carbarnate-derived acetylcholinesterase inhibitor is physostigmine 247 , an alkaloid isolated from the seeds of the Calabar bean, Physostigma venenosum. Physostigmine exhibits equal inhibitory activity against acetylcholinesterase and butyrylcholinester-ase 308 . At the pH of the body fluids, a significant proportion of physostigmine molecules is pro-tonated at N1. This cationic species participates in binding of the molecule to the catalytic domain of acetylcholinesterase, to...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/structure-activity/carbarnatederived-inhibitors.html"&gt;&lt;img src="http://www.johnnysilva.com/structure-activity/images/2011_62_241.png" style="width: 247pt; height: 123pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0zo_FeYV9_w:XW6uvM5OBls:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0zo_FeYV9_w:XW6uvM5OBls:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0zo_FeYV9_w:XW6uvM5OBls:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0zo_FeYV9_w:XW6uvM5OBls:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0zo_FeYV9_w:XW6uvM5OBls:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0zo_FeYV9_w:XW6uvM5OBls:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>StructureActivity</category>
 <link>http://www.johnnysilva.com/structure-activity/carbarnatederived-inhibitors.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/structure-activity/carbarnatederived-inhibitors.html</guid>
 <media:content url="http://www.johnnysilva.com/structure-activity/images/2011_62_241.png" type="image/png" height="172" width="346" />
 <media:title />
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 20:51:42 GMT</pubDate>
</item>
<item>
 <title>Elbow ArticularCartilage</title>
 <description>Distal location of flexion extension Source Shiba R, Sorbie C, Siu DW, Bryant JT, Cooke TDV, Weavers HW. 1988. Geometry of the humeral-ulnar joint. J Orthop Res 6 897. Source Shiba R, Sorbie C, Siu DW, Bryant JT, Cooke TDV, Weavers HW. 1988. Geometry of the humeral-ulnar joint. J Orthop Res 6 897. FIGURE 3.23 Components contributing to the carrying angles a k y. Key a, angle between C-line and TEL Y, inclination of central groove cg k, angle between trochlear notch tn y, reverse angulation of...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/articular-cartilage/elbow.html"&gt;&lt;img src="http://www.johnnysilva.com/articular-cartilage/images/1963_43_42.png" style="width: 164pt; height: 133pt;" title="Source Shiba Sorbie Siu Bryant Cooke TDV Weavers 1988 Geometry the humeral ulnar joint Orthop Res 897"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u3fRynq437g:LZrGZoBqF0w:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u3fRynq437g:LZrGZoBqF0w:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=u3fRynq437g:LZrGZoBqF0w:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u3fRynq437g:LZrGZoBqF0w:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=u3fRynq437g:LZrGZoBqF0w:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=u3fRynq437g:LZrGZoBqF0w:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ArticularCartilage</category>
 <link>http://www.johnnysilva.com/articular-cartilage/elbow.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/articular-cartilage/elbow.html</guid>
 <media:content url="http://www.johnnysilva.com/articular-cartilage/images/1963_43_42.png" type="image/png" height="186" width="230" />
 <media:title />
 <media:description type="html">Source Shiba Sorbie Siu Bryant Cooke TDV Weavers 1988 Geometry the humeral ulnar joint Orthop Res 897</media:description>
 <pubDate>Tue, 21 Feb 2012 20:42:01 GMT</pubDate>
</item>
<item>
 <title>Advantages of Combining Visual Analog Scale Measures with Sensory Tests BowelSyndrome</title>
 <description>It is not widely recognized that the VAS has measurement properties that are superior to other commonly used scales such as the NRS. Unlike VAS, the 11 point-NRS definitely does not have ratio scale properties and has no distinct zero point Fig. 4 of Ref. 13 . Compared to VAS ratings, NRS ratings have been shown to be artificially higher for both clinical and experimental pain 13 . The notion that NRS ratings can easily substitute for VAS ratings because they are highly correlated with each...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l8GOLXkAaIM:j6Q0UiduvKk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l8GOLXkAaIM:j6Q0UiduvKk:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=l8GOLXkAaIM:j6Q0UiduvKk:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l8GOLXkAaIM:j6Q0UiduvKk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=l8GOLXkAaIM:j6Q0UiduvKk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l8GOLXkAaIM:j6Q0UiduvKk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BowelSyndrome</category>
 <link>http://www.johnnysilva.com/bowel-syndrome/advantages-of-combining-visual-analog-scale-measures-with-sensory-tests.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/bowel-syndrome/advantages-of-combining-visual-analog-scale-measures-with-sensory-tests.html</guid>
 <pubDate>Tue, 21 Feb 2012 20:21:25 GMT</pubDate>
</item>
<item>
 <title>Classification JerusalemArtichoke</title>
 <description>Jerusalem artichoke is classified in the genus Helianthus L., in the family Asteraceae Aster or Daisy family , in the order Asterales Table 3.1 . Asteraceae is the modern family name, introduced to supersede Compositae under Article 18 of the International Code of Botanical Nomenclature, 1972. Compositae is used in the pre-1972 literature as the family name for Jerusalem artichoke, and it is still acceptable to use it as the family name in the same way Cruciferae, Gramineae, and Leguminoseae,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=m5-MHs2HH8s:r3_6nxgEmPU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=m5-MHs2HH8s:r3_6nxgEmPU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=m5-MHs2HH8s:r3_6nxgEmPU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=m5-MHs2HH8s:r3_6nxgEmPU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=m5-MHs2HH8s:r3_6nxgEmPU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=m5-MHs2HH8s:r3_6nxgEmPU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>JerusalemArtichoke</category>
 <link>http://www.johnnysilva.com/jerusalem-artichoke/classification.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/jerusalem-artichoke/classification.html</guid>
 <pubDate>Tue, 21 Feb 2012 20:13:41 GMT</pubDate>
</item>
<item>
 <title>Growth Hormone TestMethodology</title>
 <description>Disorders of Growth Hormone Secretion Case Scenario 11-3. Pheochromocytoma A Red-Haired Woman With a Taste for Bananas ADRENAL MEDULLARY HORMONES DISORDERS OF ADRENAL MEDULLARY HORMONES Pheochromocytomas Neuroblastomas LABORATORY TESTING FOR ADRENAL MEDULLARY DISORDERS Case Scenario 11-4. Neonatal Hypothyroidism Repeat Thyroid Testing on a Baby ROLE OF ENDOCRINE GLANDS IN THYROID FUNCTION Thyroid-Stimulating Hormone Pituitary Hormone Thyroid Hormone Metabolism Hypothyroidism Case Scenario 11-5....&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ibBWhIbxBD4:vkHW5aX-XiM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ibBWhIbxBD4:vkHW5aX-XiM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=ibBWhIbxBD4:vkHW5aX-XiM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ibBWhIbxBD4:vkHW5aX-XiM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=ibBWhIbxBD4:vkHW5aX-XiM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ibBWhIbxBD4:vkHW5aX-XiM:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TestMethodology</category>
 <link>http://www.johnnysilva.com/test-methodology/growth-hormone.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/test-methodology/growth-hormone.html</guid>
 <pubDate>Tue, 21 Feb 2012 19:24:57 GMT</pubDate>
</item>
<item>
 <title>Case Scenario 111 TestMethodology</title>
 <description>Type 2 Diabetes With Cardiac Risk Mildred Dodge, the Bonbon Eater Apolipoprotein A Deficiency The Jogger Congestive Heart Failure Joe Returns Silent Myocardial Infarction Woman at Risk Medication Toxicity Age-Related Drug Distribution The Clot Thickens Joe Returns Again Arterial Blood Gas Collection and Specimen Handling The Case of the Pink Patient With a Dark Blood Sample Chronic Bronchitis Blue Bloater or Pink Puffer Patient Acute Respiratory Failure Pain Medication Made Things Worse...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wHPjYqNcpWg:xu49_tZBf8s:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wHPjYqNcpWg:xu49_tZBf8s:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=wHPjYqNcpWg:xu49_tZBf8s:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wHPjYqNcpWg:xu49_tZBf8s:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=wHPjYqNcpWg:xu49_tZBf8s:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=wHPjYqNcpWg:xu49_tZBf8s:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TestMethodology</category>
 <link>http://www.johnnysilva.com/test-methodology/case-scenario-111.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/test-methodology/case-scenario-111.html</guid>
 <pubDate>Tue, 21 Feb 2012 19:24:23 GMT</pubDate>
</item>
<item>
 <title>Cox 2 TumorMarker</title>
 <description>Cyclooxygenase COX enzymes catalyze the first step in the conversion of arachidonic acid to prostaglandins. There are two isoforms, COX-1 and COX-2 both are glycoproteins and sit on the nuclear membrane. Both COX isoforms are normally absent in most cells but can be transiently up-regulated in response to growth factors and cytokines. Recently it was found that COX-2 appears to play an emerging role in inflammation and carcinogenesis. Overexpression of COX-2 inhibits apoptosis, which could...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=APzRoOkUDUE:7uK8h15nNu0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=APzRoOkUDUE:7uK8h15nNu0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=APzRoOkUDUE:7uK8h15nNu0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=APzRoOkUDUE:7uK8h15nNu0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=APzRoOkUDUE:7uK8h15nNu0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=APzRoOkUDUE:7uK8h15nNu0:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TumorMarker</category>
 <link>http://www.johnnysilva.com/tumor-marker/cox-2.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/tumor-marker/cox-2.html</guid>
 <pubDate>Tue, 21 Feb 2012 17:15:05 GMT</pubDate>
</item>
<item>
 <title>References Ueq HemodialysisPatients</title>
 <description>1 KDOQI National Kidney Foundation II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006 47 suppl 3 S16-S85. 2 Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998 339 584-590. 3 Parfrey PS, Foley RN, Wittreich BH,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=DKIbNhnyPg8:gyZJ3Yzqo3g:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=DKIbNhnyPg8:gyZJ3Yzqo3g:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=DKIbNhnyPg8:gyZJ3Yzqo3g:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=DKIbNhnyPg8:gyZJ3Yzqo3g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=DKIbNhnyPg8:gyZJ3Yzqo3g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=DKIbNhnyPg8:gyZJ3Yzqo3g:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>HemodialysisPatients</category>
 <link>http://www.johnnysilva.com/hemodialysis-patients/references-ueq.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/hemodialysis-patients/references-ueq.html</guid>
 <pubDate>Tue, 21 Feb 2012 17:04:11 GMT</pubDate>
</item>
<item>
 <title>B Wbd PeriodontalDisease</title>
 <description>Fig. 16-2 Human biopsy, experimental gingivitis. A, Control biopsy specimen from a patient with good oral hygiene and no detectable plaque accumulation, the junctional epithelium is at the left. The connective tissue CT shows few cells other than fibroblasts, blood vessels, and a dense background of collagen fillers Magnification 500. B, Biopsy specimen taken after 8 days of plaque accumulation. The connective tissue is infiltrated with inflammatory cells, which displace the collagen fibers. A...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/periodontal-disease/b-wbd.html"&gt;&lt;img src="http://www.johnnysilva.com/periodontal-disease/images/2051_222_258.jpg" style="width: 211pt; height: 233pt;" title="Fig Established gingivitis human subject area crevicular epithelium exhibiting enlarged intercellular spaces with numerous microvilli and desmosomal junctions Several lymphocytes both small and large are seen migrating through the epithelial layer Magnific"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=mkunJTzP2TQ:gVK4dHtlnSU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=mkunJTzP2TQ:gVK4dHtlnSU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=mkunJTzP2TQ:gVK4dHtlnSU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=mkunJTzP2TQ:gVK4dHtlnSU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=mkunJTzP2TQ:gVK4dHtlnSU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=mkunJTzP2TQ:gVK4dHtlnSU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PeriodontalDisease</category>
 <link>http://www.johnnysilva.com/periodontal-disease/b-wbd.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/periodontal-disease/b-wbd.html</guid>
 <media:content url="http://www.johnnysilva.com/periodontal-disease/images/2051_222_258.jpg" type="image/jpeg" height="326" width="295" />
 <media:title />
 <media:description type="html">Fig Established gingivitis human subject area crevicular epithelium exhibiting enlarged intercellular spaces with numerous microvilli and desmosomal junctions Several lymphocytes both small and large are seen migrating through the epithelial layer Magnific</media:description>
 <pubDate>Tue, 21 Feb 2012 16:05:16 GMT</pubDate>
</item>
<item>
 <title>Venous Return And Cardiac Output ArterialPressure</title>
 <description>The Balance between Venous Return and Cardiac Output Venous return is the flow of blood back to the heart. Previous sections described how the venous return to the right atrium from the abdominal vena cava is determined by the pressure gradient between the abdominal vena cava and the right atrium, divided by the resistance of the vena cava. However, that analysis looks at only a short segment of the venous system and does not show what factors determine venous return from the capillaries....&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Pli65dCQ-Zg:XPSbSBJfJzo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Pli65dCQ-Zg:XPSbSBJfJzo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Pli65dCQ-Zg:XPSbSBJfJzo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Pli65dCQ-Zg:XPSbSBJfJzo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Pli65dCQ-Zg:XPSbSBJfJzo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Pli65dCQ-Zg:XPSbSBJfJzo:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ArterialPressure</category>
 <link>http://www.johnnysilva.com/arterial-pressure/venous-return-and-cardiac-output.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/arterial-pressure/venous-return-and-cardiac-output.html</guid>
 <pubDate>Tue, 21 Feb 2012 15:51:29 GMT</pubDate>
</item>
<item>
 <title>B Neutralization of the Antiprotease Effects of Heparin Derivatives HeparanSulfate</title>
 <description>The antiprotease effects of heparin derivatives can be neutralized by platelet factor 4 PF4 , protamine sulfate, polybrene, and histidine rich glycoprotein. Studies have shown that the specific antiprotease activities of heparin derivatives are differentially neutralized i.e., the anti-factor Ha activity can be fully neutralized whereas the anti-factor Xa activity of the same agent may only be partially neutralized 71 . The anti-factor Xa activity of a decasaccharide was found to be...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=pSCBUzA8_Yo:L0vYba8HE1U:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=pSCBUzA8_Yo:L0vYba8HE1U:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=pSCBUzA8_Yo:L0vYba8HE1U:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=pSCBUzA8_Yo:L0vYba8HE1U:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=pSCBUzA8_Yo:L0vYba8HE1U:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=pSCBUzA8_Yo:L0vYba8HE1U:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>HeparanSulfate</category>
 <link>http://www.johnnysilva.com/heparan-sulfate/b-neutralization-of-the-antiprotease-effects-of-heparin-derivatives.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/heparan-sulfate/b-neutralization-of-the-antiprotease-effects-of-heparin-derivatives.html</guid>
 <pubDate>Tue, 21 Feb 2012 15:25:47 GMT</pubDate>
</item>
<item>
 <title>Diagnosis Physical Examination 2</title>
 <description>The test of choice for the determination of the source of lower GI bleeding is colonoscopy. Adequate bowel preparation with an oral sulfate purge to clear the bowel of blood, clots, and stool increases the yield in diagnosing colonic bleeding sites. Angiography and technetium-labeled colloid or red blood cell scans may be of value if colonoscopy cannot be performed or if heavy bleeding prevents adequate visualization of the colon. However, the magnitude of bleeding required to show the bleeding...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dSyTIRRE5wM:G_Zfi1lG298:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dSyTIRRE5wM:G_Zfi1lG298:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=dSyTIRRE5wM:G_Zfi1lG298:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dSyTIRRE5wM:G_Zfi1lG298:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=dSyTIRRE5wM:G_Zfi1lG298:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=dSyTIRRE5wM:G_Zfi1lG298:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <link>http://www.johnnysilva.com/physical-examination-2/diagnosis.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/physical-examination-2/diagnosis.html</guid>
 <pubDate>Tue, 21 Feb 2012 14:39:52 GMT</pubDate>
</item>
<item>
 <title>ABCA1 in Macrophage Lipid Transport BindingProteins</title>
 <description>Several factors control the expression and activity of ABCA1. Induced cholesterol influx into macrophage cells has been shown to be a potent inducer of ABCA1 expression 40 . Since the cloning of the complete human and mouse ABCA1 genes, a number of transcriptional control elements acting via alternative promoters have been characterized 197-199 Fig. 3.6 . The ABCA1 upstream region contains a macrophage-specific promoter preceding exon 1. This sequence binds the repressors ZNF202 and USF1 2, as...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/binding-proteins/abca1-in-macrophage-lipid-transport.html"&gt;&lt;img src="http://www.johnnysilva.com/binding-proteins/images/2069_64_11.jpg" style="width: 324pt; height: 202pt;" title="HDL pathway"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=AIZlb7dlY_M:Hkw8ibDZ7zI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=AIZlb7dlY_M:Hkw8ibDZ7zI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=AIZlb7dlY_M:Hkw8ibDZ7zI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=AIZlb7dlY_M:Hkw8ibDZ7zI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=AIZlb7dlY_M:Hkw8ibDZ7zI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=AIZlb7dlY_M:Hkw8ibDZ7zI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BindingProteins</category>
 <link>http://www.johnnysilva.com/binding-proteins/abca1-in-macrophage-lipid-transport.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/binding-proteins/abca1-in-macrophage-lipid-transport.html</guid>
 <media:content url="http://www.johnnysilva.com/binding-proteins/images/2069_64_11.jpg" type="image/jpeg" height="283" width="454" />
 <media:title />
 <media:description type="html">HDL pathway</media:description>
 <pubDate>Tue, 21 Feb 2012 14:21:26 GMT</pubDate>
</item>
<item>
 <title>Crystalloid Solutions BloodSubstitutes</title>
 <description>A crystalloid solution contains small particles that are composed of low molecular weight solutes lt 30 000 D that can be either ionic e.g. Na , CT or non-ionic e.g. glucose, mannitol . Crystalloid fluids are inexpensive compared with blood products and artificial colloids. The contents of a number of commonly used crystalloids are listed in Table 11.1. The systemic distribution of crystalloids is dependent on the amount of sodium in the solution. Solutions that contain approximately isotonic...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/blood-substitutes/crystalloid-solutions.html"&gt;&lt;img src="http://www.johnnysilva.com/blood-substitutes/images/1981_126_35.jpg" style="width: 181pt; height: 40pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BmdNZA8wO6c:6oRzCgwAKbE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BmdNZA8wO6c:6oRzCgwAKbE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=BmdNZA8wO6c:6oRzCgwAKbE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BmdNZA8wO6c:6oRzCgwAKbE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=BmdNZA8wO6c:6oRzCgwAKbE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=BmdNZA8wO6c:6oRzCgwAKbE:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BloodSubstitutes</category>
 <link>http://www.johnnysilva.com/blood-substitutes/crystalloid-solutions.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/blood-substitutes/crystalloid-solutions.html</guid>
 <media:content url="http://www.johnnysilva.com/blood-substitutes/images/1981_126_35.jpg" type="image/jpeg" height="56" width="253" />
 <media:title />
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 14:11:18 GMT</pubDate>
</item>
<item>
 <title>Identification of Herb and Resin CannabisProducts</title>
 <description>The first stage of laboratory identification, screening for the presence of any cannabis product in the forensic sample, may have been pre-empted by a report of a positive field test. Otherwise, note is taken of the macroscopic appearance this is highly characteristic in bulk samples of herb and slabs of resin but may be more difficult to distinguish in highly comminuted material. More persuasive examination involves light microscopy see 3.3.2 and colour tests see 3.3.3 , with convenient...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OhFEajWUPnU:v_Vu6N48R9A:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OhFEajWUPnU:v_Vu6N48R9A:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=OhFEajWUPnU:v_Vu6N48R9A:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OhFEajWUPnU:v_Vu6N48R9A:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=OhFEajWUPnU:v_Vu6N48R9A:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=OhFEajWUPnU:v_Vu6N48R9A:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CannabisProducts</category>
 <link>http://www.johnnysilva.com/cannabis-products/identification-of-herb-and-resin.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cannabis-products/identification-of-herb-and-resin.html</guid>
 <pubDate>Tue, 21 Feb 2012 13:58:41 GMT</pubDate>
</item>
<item>
 <title>Caspases In Apoptotic Cell Death CalciumBinding</title>
 <description>Calcium-mediated activation of caspases is also associated with apoptosis. The apoptotic pathway involves a cascade of proteolytic events mediated by caspases, their activators, and their repressors. Caspases are cysteine proteases of a family of interleukin-1p-converting enzymes ICE . A number of proteases ced-3, ced-4, and ced-9 have been identified in the nematode C. elegans. Of these, ced-3 is a caspase. A human homologue of the ced-4 protein, called apaf-1, has been described Zou et al....&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=KCuGk1sQtWU:anJG3sR2V4o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=KCuGk1sQtWU:anJG3sR2V4o:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=KCuGk1sQtWU:anJG3sR2V4o:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=KCuGk1sQtWU:anJG3sR2V4o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=KCuGk1sQtWU:anJG3sR2V4o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=KCuGk1sQtWU:anJG3sR2V4o:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CalciumBinding</category>
 <link>http://www.johnnysilva.com/calcium-binding/caspases-in-apoptotic-cell-death.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/calcium-binding/caspases-in-apoptotic-cell-death.html</guid>
 <pubDate>Tue, 21 Feb 2012 13:53:57 GMT</pubDate>
</item>
<item>
 <title>CS Malononitrile and CN ForensicMedicine</title>
 <description>CS, or tear gas, is used frequently by the military and law enforcement as a method of controlling both individuals and crowds. The military also uses it during exercises to train personnel in the use of protective equipment. CN, known by its common name, Mace , is the oldest of the crowd-control agents. CS was developed in the 1950s, and it has largely replaced the use of CN. CS and CN are both lacrimating agents. CS is usually mixed with a pyrotechnic compound for dispersal in grenades or...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3TbcAtb19bk:F4zmDVbOiKw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3TbcAtb19bk:F4zmDVbOiKw:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=3TbcAtb19bk:F4zmDVbOiKw:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3TbcAtb19bk:F4zmDVbOiKw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=3TbcAtb19bk:F4zmDVbOiKw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3TbcAtb19bk:F4zmDVbOiKw:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ForensicMedicine</category>
 <link>http://www.johnnysilva.com/forensic-medicine/cs-malononitrile-and-cn.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/forensic-medicine/cs-malononitrile-and-cn.html</guid>
 <pubDate>Tue, 21 Feb 2012 13:32:20 GMT</pubDate>
</item>
<item>
 <title>Y Ardo 1 CheddarCheese</title>
 <description>During ripening, several biochemical processes 88 contribute to the development of typical structure and flavour of each Blue cheese variety. Some of the processes may produce pigment if the enzymes needed are present and the environment in the cheese stimulates its production. Brown spots in a Blue cheese are commonly of microbial origin and may be developed by contaminating yeasts or moulds. It may also be a result of highly active Penicillium roqueforti in long-ripened cheese, and...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=hL6CFfx1uwo:Ne3Nga64BLA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=hL6CFfx1uwo:Ne3Nga64BLA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=hL6CFfx1uwo:Ne3Nga64BLA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=hL6CFfx1uwo:Ne3Nga64BLA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=hL6CFfx1uwo:Ne3Nga64BLA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=hL6CFfx1uwo:Ne3Nga64BLA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CheddarCheese</category>
 <link>http://www.johnnysilva.com/cheddar-cheese/y-ardo-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cheddar-cheese/y-ardo-1.html</guid>
 <pubDate>Tue, 21 Feb 2012 13:12:09 GMT</pubDate>
</item>
<item>
 <title>Contents ChromatinStructure</title>
 <description>PART I CHROMATIN STRUCTURE, DYNAMICS AND DISEASE 1 1 Structural Organization of Dynamic Chromatin 3 Kohji Hizume, Shige H. Yoshimura, Masahiro Kumeta and Kunio Takeyasu 2 ATP-Dependent Chromatin Remodelling Action and Reaction 29 Parul Choudhary and Patrick Varga-Weisz 3 Regulation of Chromatin Structure and Chromatin-Dependent Transcription by Poly ADP-Ribose Polymerase-1 Possible targets David A. Wacker, Kristine M. Frizzell, Tong Zhang and W. Lee Kraus 4 Histone Variant Nucleosomes...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=exDb3YulGTk:MgspF7g4VSw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=exDb3YulGTk:MgspF7g4VSw:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=exDb3YulGTk:MgspF7g4VSw:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=exDb3YulGTk:MgspF7g4VSw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=exDb3YulGTk:MgspF7g4VSw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=exDb3YulGTk:MgspF7g4VSw:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ChromatinStructure</category>
 <link>http://www.johnnysilva.com/chromatin-structure/contents.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/chromatin-structure/contents.html</guid>
 <pubDate>Tue, 21 Feb 2012 13:01:11 GMT</pubDate>
</item>
<item>
 <title>The Role and Responsibilities of the Nurse CardiacRehabilitation</title>
 <description>A central issue to explore is the role and responsibility of nurses in heart failure programs. Among all tasks, nurses have formal competence for some, delegated responsibility for others, while some extended tasks need additional training and education. There are huge differences both within and between countries regarding the education and competencies of registered nurses. There are legal differences as to what nurses are allowed to do within their license. The whole team needs to agree on...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YUhgwC0845k:NMaVmL3azts:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YUhgwC0845k:NMaVmL3azts:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=YUhgwC0845k:NMaVmL3azts:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YUhgwC0845k:NMaVmL3azts:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=YUhgwC0845k:NMaVmL3azts:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=YUhgwC0845k:NMaVmL3azts:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CardiacRehabilitation</category>
 <link>http://www.johnnysilva.com/cardiac-rehabilitation/the-role-and-responsibilities-of-the-nurse.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cardiac-rehabilitation/the-role-and-responsibilities-of-the-nurse.html</guid>
 <pubDate>Tue, 21 Feb 2012 12:37:44 GMT</pubDate>
</item>
<item>
 <title>References Erk CarbonicAnhydrase</title>
 <description>Abbate, F., Supuran, C.T., Scozzafava, A., Orioli, P., Stubbs, M.T. and Klebe, G. 2002 Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhy-drase inhibitors Role of hydrogen-bonding networks in ligand binding and drug design. Journal of Medicinal Chemistry 45, 3583-3587. Antel, J. 1999 Integration of combinatorial chemistry and structure-based drug design. Current Opinion in Drug Discovery and Development 2, 224-233. Aribi, A.M., and Stringer, J.L. 2002 Effects of...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2W2n6A6OHTA:SL0_A1csh7I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2W2n6A6OHTA:SL0_A1csh7I:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=2W2n6A6OHTA:SL0_A1csh7I:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2W2n6A6OHTA:SL0_A1csh7I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=2W2n6A6OHTA:SL0_A1csh7I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=2W2n6A6OHTA:SL0_A1csh7I:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CarbonicAnhydrase</category>
 <link>http://www.johnnysilva.com/carbonic-anhydrase/references-erk.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/carbonic-anhydrase/references-erk.html</guid>
 <pubDate>Tue, 21 Feb 2012 11:03:54 GMT</pubDate>
</item>
<item>
 <title>Right Eardrum 1 PhysicalExamination</title>
 <description>Inspect the eardrum, noting its color and contour. The cone of light usually easy to see helps to orient you. Identify the handle of the malleus, noting its position, and inspect the short process of the malleus. Gently move the speculum so that you can see as much of the drum as possible, including the pars flaccida superiorly and the margins of the pars tensa. Look for any perforations. The anterior and inferior margins of the drum may be obscured by the curving wall of the ear canal....&lt;p&gt;&lt;a href="http://www.johnnysilva.com/physical-examination/right-eardrum-1.html"&gt;&lt;img src="http://www.johnnysilva.com/physical-examination/images/1912_104_157.jpg" style="width: 156pt; height: 156pt;" title="Using the pads the 2nd and 3rd fingers palpate the preauricular nodes with gentle rotary motion Then examine the posterior auricular and occipital lymph nodes"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ulzcsyyYMxg:gmkOck3ugN8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ulzcsyyYMxg:gmkOck3ugN8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=ulzcsyyYMxg:gmkOck3ugN8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ulzcsyyYMxg:gmkOck3ugN8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=ulzcsyyYMxg:gmkOck3ugN8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=ulzcsyyYMxg:gmkOck3ugN8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PhysicalExamination</category>
 <link>http://www.johnnysilva.com/physical-examination/right-eardrum-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/physical-examination/right-eardrum-1.html</guid>
 <media:content url="http://www.johnnysilva.com/physical-examination/images/1912_104_157.jpg" type="image/jpeg" height="218" width="218" />
 <media:title />
 <media:description type="html">Using the pads the 2nd and 3rd fingers palpate the preauricular nodes with gentle rotary motion Then examine the posterior auricular and occipital lymph nodes</media:description>
 <pubDate>Tue, 21 Feb 2012 10:46:44 GMT</pubDate>
</item>
<item>
 <title>Structure of FATPs BindingProteins</title>
 <description>FATP1 is a 646 amino acid protein that is expressed in cells and tissues with high-level fatty acid import for metabolism or storage 25 . Expression of FATP1 in mammalian cells increases import of radiolabeled and fluorescently labeled LCFAs and very long-chain fatty acids VLCFAs , but not medium-chain substrates. FATP1 is a member of a large family of related proteins from diverse organisms including Saccharomyces cerevisiae, Caenorhabditis elegans, Mycobacterium tuberculosis, rats, mice, and...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=C0yy909J3ck:gpj6_LMt_k8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=C0yy909J3ck:gpj6_LMt_k8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=C0yy909J3ck:gpj6_LMt_k8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=C0yy909J3ck:gpj6_LMt_k8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=C0yy909J3ck:gpj6_LMt_k8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=C0yy909J3ck:gpj6_LMt_k8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BindingProteins</category>
 <link>http://www.johnnysilva.com/binding-proteins/structure-of-fatps.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/binding-proteins/structure-of-fatps.html</guid>
 <pubDate>Tue, 21 Feb 2012 09:34:03 GMT</pubDate>
</item>
<item>
 <title>Secondary Accession Numbers HumanGenome</title>
 <description>From Figure 4.1 we can read eight secondary accession numbers that designate protein translations for each of the BACE mRNAs. It also has three RefSeq numbers NM_012104 for the mRNA, NP.036236 for the protein and NT_009151 for the genomic contig. There is one SwissProt accession BACE_HUMAN P56817 and one TREMBL splice variant Q9BYB9. The LocusID, 23621, in turn links out to many other accession numbers which point to the BACE genome sequence. These include the Hs.49349 UniGene cluster that...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=677EmjTFTtk:3mt_oMPPObw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=677EmjTFTtk:3mt_oMPPObw:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=677EmjTFTtk:3mt_oMPPObw:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=677EmjTFTtk:3mt_oMPPObw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=677EmjTFTtk:3mt_oMPPObw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=677EmjTFTtk:3mt_oMPPObw:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>HumanGenome</category>
 <link>http://www.johnnysilva.com/human-genome/secondary-accession-numbers.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/human-genome/secondary-accession-numbers.html</guid>
 <pubDate>Tue, 21 Feb 2012 08:27:34 GMT</pubDate>
</item>
<item>
 <title>Immunophenotype 1 CellTransplantation</title>
 <description>The immunophenotype of lymphomas was first used in the Kiel classification for broad grouping of lymphomas into B-cell and T-cell types. With the inclusion of the NK-cell lymphomas into the T-cell group, this distinction remains a fundamental consideration in the REAL classification and serves as a primary step in the separation of the lymphomas into two broad groups. Within these broad groupings the detailed immunophenotype is useful in helping to define individual entities but in only a few...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5hjbdrIbSug:bOIQx5JHC5k:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5hjbdrIbSug:bOIQx5JHC5k:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=5hjbdrIbSug:bOIQx5JHC5k:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5hjbdrIbSug:bOIQx5JHC5k:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=5hjbdrIbSug:bOIQx5JHC5k:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5hjbdrIbSug:bOIQx5JHC5k:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CellTransplantation</category>
 <link>http://www.johnnysilva.com/cell-transplantation/immunophenotype-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cell-transplantation/immunophenotype-1.html</guid>
 <pubDate>Tue, 21 Feb 2012 07:48:46 GMT</pubDate>
</item>
<item>
 <title>Rcooh Mass Spectrometry 3</title>
 <description>R-NH2 in primary amines, amino acids and amino sugars R'-NH-R in secondary amines, amino acids, substituted amino sugars Thiourea formation Schiff's base formation Carbamate formation Alkylation 2,4-Dinitrophenylation Sulphonamide formation Ion pair formation Esterification acylation Silylation Placing the doped fiber into gaseous phase or headspace above aqueous phase in reaction vial for in-fiber derivatization SPME Fiber desorption, separation, and quantitation FIGURE 2.38 In-coating...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/mass-spectrometry-3/rcooh.html"&gt;&lt;img src="http://www.johnnysilva.com/mass-spectrometry-3/images/2104_48_40.jpg" style="width: 79pt; height: 75pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=S0pCDA0atGY:cj8rt8G-TDI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=S0pCDA0atGY:cj8rt8G-TDI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=S0pCDA0atGY:cj8rt8G-TDI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=S0pCDA0atGY:cj8rt8G-TDI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=S0pCDA0atGY:cj8rt8G-TDI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=S0pCDA0atGY:cj8rt8G-TDI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <link>http://www.johnnysilva.com/mass-spectrometry-3/rcooh.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/mass-spectrometry-3/rcooh.html</guid>
 <media:content url="http://www.johnnysilva.com/mass-spectrometry-3/images/2104_48_40.jpg" type="image/jpeg" height="105" width="111" />
 <media:title />
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 07:24:16 GMT</pubDate>
</item>
<item>
 <title>Test Methodology 103 Schilling Test TestMethodology</title>
 <description>The Schilling test is a test for vitamin B12 absorption. The test requires the cooperation of both the laboratory and the nuclear medicine department. The test is used to differentiate the three main causes of vitamin B12 deficiency dietary deficiency, malabsorption of B12, and pernicious anemia. The Schilling test is a two-step procedure. If results in the first step indicate normal absorption, there is no need to perform the second step of the test. The patient must be fasting. The patient...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LOBLONqj2Ww:iLQbyOUYQdA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LOBLONqj2Ww:iLQbyOUYQdA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LOBLONqj2Ww:iLQbyOUYQdA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LOBLONqj2Ww:iLQbyOUYQdA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LOBLONqj2Ww:iLQbyOUYQdA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LOBLONqj2Ww:iLQbyOUYQdA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TestMethodology</category>
 <link>http://www.johnnysilva.com/test-methodology/test-methodology-103-schilling-test.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/test-methodology/test-methodology-103-schilling-test.html</guid>
 <pubDate>Tue, 21 Feb 2012 06:55:50 GMT</pubDate>
</item>
<item>
 <title>Advantages And Limitations Of Conventional Tumor Makers In Serum TumorMarker</title>
 <description>The development of tumor specific epitopes or molecules has been elusive in spite of research efforts in science and medicine. Table 1 shows the overall characteristics of popular tumor markers in serum 16-25 , selected among over 100 markers reported in the past 50 yr 4 . CEA 1 was identified from tumor tissue of colorectal cancer patients through serological adsorption using adjacent normal tissue, a technique similar to the subtraction method using gene cloning. In terms of sensitivity and...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/tumor-marker/advantages-and-limitations-of-conventional-tumor-makers-in-serum.html"&gt;&lt;img src="http://www.johnnysilva.com/tumor-marker/images/2024_10_1.jpg" style="width: 338pt; height: 191pt;" title="Fig Relation between sensitivity and disease progression for typical tumor markers"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0GznRr9tkWk:I6Y97oK683s:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0GznRr9tkWk:I6Y97oK683s:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0GznRr9tkWk:I6Y97oK683s:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0GznRr9tkWk:I6Y97oK683s:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0GznRr9tkWk:I6Y97oK683s:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0GznRr9tkWk:I6Y97oK683s:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>TumorMarker</category>
 <link>http://www.johnnysilva.com/tumor-marker/advantages-and-limitations-of-conventional-tumor-makers-in-serum.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/tumor-marker/advantages-and-limitations-of-conventional-tumor-makers-in-serum.html</guid>
 <media:content url="http://www.johnnysilva.com/tumor-marker/images/2024_10_1.jpg" type="image/jpeg" height="267" width="473" />
 <media:title />
 <media:description type="html">Fig Relation between sensitivity and disease progression for typical tumor markers</media:description>
 <pubDate>Tue, 21 Feb 2012 06:22:06 GMT</pubDate>
</item>
<item>
 <title>Cannabis Oils and Cannabinoids CannabisProducts</title>
 <description>Crude mixtures of cannabinoids, particularly oily extracts of cannabis, require individual identification and sometimes quantitation of the controlled ingredients. TLC methods are of first choice for speed and simplicity as qualitative tests and have some value in assessing relative levels of congeners provided it is admitted that TLC is, at best, only semi-quantitative 5 coefficient of variation for quantity and 2-3 reproducibility of Rf values. This can be improved at least two-fold when...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/cannabis-products/cannabis-oils-and-cannabinoids.html"&gt;&lt;img src="http://www.johnnysilva.com/cannabis-products/images/2034_68_16.jpg" style="width: 302pt; height: 286pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=a3jH8rWTiwo:BjiLBmlwyxo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=a3jH8rWTiwo:BjiLBmlwyxo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=a3jH8rWTiwo:BjiLBmlwyxo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=a3jH8rWTiwo:BjiLBmlwyxo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=a3jH8rWTiwo:BjiLBmlwyxo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=a3jH8rWTiwo:BjiLBmlwyxo:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CannabisProducts</category>
 <link>http://www.johnnysilva.com/cannabis-products/cannabis-oils-and-cannabinoids.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cannabis-products/cannabis-oils-and-cannabinoids.html</guid>
 <media:content url="http://www.johnnysilva.com/cannabis-products/images/2034_68_16.jpg" type="image/jpeg" height="400" width="423" />
 <media:title />
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 06:19:15 GMT</pubDate>
</item>
<item>
 <title>BPrimary OpenAngle Glaucoma HyaluronicAcid</title>
 <description>In the POAG iris, ciliary body and anterior sclera, hyaluronic content is less and chondroitin sulfate content is more, suggesting that a depletion of hyaluronan and an accumulation of chondroitin sulfate might increase aqueous outflow resistance in the POAG trabecular meshwork 132 . Addition of ascorbic acid to the trabecular meshwork cell culture medium results in the dose-dependent stimulation of hyaluronan-synthesis and secretion, which is relatively stronger in cells from glaucomatous...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=GqW2s5Mn_As:e8ebs3R9BCI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=GqW2s5Mn_As:e8ebs3R9BCI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=GqW2s5Mn_As:e8ebs3R9BCI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=GqW2s5Mn_As:e8ebs3R9BCI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=GqW2s5Mn_As:e8ebs3R9BCI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=GqW2s5Mn_As:e8ebs3R9BCI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>HyaluronicAcid</category>
 <link>http://www.johnnysilva.com/hyaluronic-acid/bprimary-openangle-glaucoma.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/hyaluronic-acid/bprimary-openangle-glaucoma.html</guid>
 <pubDate>Tue, 21 Feb 2012 06:09:05 GMT</pubDate>
</item>
<item>
 <title>See also Covalent Bonds vs NonCovalent Forces DNA Secondary Structure from Chapter 2 Dynamics of Protein Folding FattyAcids</title>
 <description>Figure 2.2 Types of noncovalent interactions. i - Figure 2.2 Types of noncovalent interactions. i - &lt;p&gt;&lt;a href="http://www.johnnysilva.com/fatty-acids/see-also-covalent-bonds-vs-noncovalent-forces-dna-secondary-structure-from-chapter-2-dynamics-of-protein-folding.html"&gt;&lt;img src="http://www.johnnysilva.com/fatty-acids/images/1925_230_183-noncovalent-forces.jpg" style="width: 367pt; height: 306pt;" alt="Noncovalent Forces"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=-9Kkk3FhG8M:Ng9Cq9RsR8w:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=-9Kkk3FhG8M:Ng9Cq9RsR8w:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=-9Kkk3FhG8M:Ng9Cq9RsR8w:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=-9Kkk3FhG8M:Ng9Cq9RsR8w:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=-9Kkk3FhG8M:Ng9Cq9RsR8w:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=-9Kkk3FhG8M:Ng9Cq9RsR8w:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>FattyAcids</category>
 <link>http://www.johnnysilva.com/fatty-acids/see-also-covalent-bonds-vs-noncovalent-forces-dna-secondary-structure-from-chapter-2-dynamics-of-protein-folding.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/fatty-acids/see-also-covalent-bonds-vs-noncovalent-forces-dna-secondary-structure-from-chapter-2-dynamics-of-protein-folding.html</guid>
 <media:content url="http://www.johnnysilva.com/fatty-acids/images/1925_230_183-noncovalent-forces.jpg" type="image/jpeg" height="428" width="514" />
 <media:title>Noncovalent Forces</media:title>
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 05:55:48 GMT</pubDate>
</item>
<item>
 <title>References Jfo LifeSpan</title>
 <description>1. F Debusk. The Hutchinson-Gilford progeria syndrome. J Pediatr 80 697-724, 1972. 2. WT Brown, M Zebrower, F Kieras. Progeria, a Model Disease for the Study of Accelerated Aging. In A Woodhead, AD Blackett, A Hollaender, eds. Molecular Biology of Aging. New York Plenum Press, 1985, pp 375-396. WT Brown. Progeria a human-disease model of accelerated aging. Am J Clin Nutr 55 1222S-1224S, 1992. WT Brown. Human mutations affecting aging a review. Mech Age Dev 9 325-326, 1979. WJ Hamilton. The...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0Mbg71nJ-TA:5FLwnQ7LmAo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0Mbg71nJ-TA:5FLwnQ7LmAo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0Mbg71nJ-TA:5FLwnQ7LmAo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0Mbg71nJ-TA:5FLwnQ7LmAo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0Mbg71nJ-TA:5FLwnQ7LmAo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0Mbg71nJ-TA:5FLwnQ7LmAo:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>LifeSpan</category>
 <link>http://www.johnnysilva.com/life-span/references-jfo.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/life-span/references-jfo.html</guid>
 <pubDate>Tue, 21 Feb 2012 04:53:55 GMT</pubDate>
</item>
<item>
 <title>Thoracotomy for Lead Extraction VentricularPacing</title>
 <description>There has been a natural reticence even among surgeons to remove leads at thoracotomy. While there is no randomized data comparing the two techniques, the Accufix experience suggests no clinically significant difference in the incidence of death or major complications. This is not surprising considering the advanced age and co-morbidity of many pacemaker patients. Surgery however may be the only alternative in situations in which percutaneous techniques have failed and there is an absolute...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LBhuh3XnEcI:FTWcPthknso:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LBhuh3XnEcI:FTWcPthknso:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LBhuh3XnEcI:FTWcPthknso:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LBhuh3XnEcI:FTWcPthknso:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LBhuh3XnEcI:FTWcPthknso:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LBhuh3XnEcI:FTWcPthknso:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>VentricularPacing</category>
 <link>http://www.johnnysilva.com/ventricular-pacing/thoracotomy-for-lead-extraction.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/ventricular-pacing/thoracotomy-for-lead-extraction.html</guid>
 <pubDate>Tue, 21 Feb 2012 04:47:54 GMT</pubDate>
</item>
<item>
 <title>Evidence for Autonomic Nervous System Dysfunction BowelSyndrome</title>
 <description>A number of studies have addressed the role of the ANS in modulating visceral perception in FGD. Chen and Orr demonstrated enhanced sympathetic dominance to esophageal acid infusion in patients with gastroesophageal reflux disease GERD , which appeared to be secondary to decreased vagal tone in these subjects 121 . During acid infusion, there was a significant decrease in LF band power a measure of sympathetic tone in the control group, which was unchanged in the patient group, whereas the HF...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=xM6rsvx9APE:Fvn0XMFww6U:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=xM6rsvx9APE:Fvn0XMFww6U:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=xM6rsvx9APE:Fvn0XMFww6U:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=xM6rsvx9APE:Fvn0XMFww6U:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=xM6rsvx9APE:Fvn0XMFww6U:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=xM6rsvx9APE:Fvn0XMFww6U:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BowelSyndrome</category>
 <link>http://www.johnnysilva.com/bowel-syndrome/evidence-for-autonomic-nervous-system-dysfunction.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/bowel-syndrome/evidence-for-autonomic-nervous-system-dysfunction.html</guid>
 <pubDate>Tue, 21 Feb 2012 02:50:04 GMT</pubDate>
</item>
<item>
 <title>Intraosseous ganglion KienbockDisease</title>
 <description>The most common carpal lesion is the intra-osseous ganglion IOG . Also known as a subchon-dral bone cyst, the IOG is a benign, mucin-filled, cystlike lesion that arises within the subchondral medullary bone. IOGs are regularly seen on wrist radiographs obtained to evaluate wrist pain or other problems. In a radiographic study of 280 cadaveric wrists, Schrank and colleagues 1 identified an overall 9.6 incidence of carpal ganglion cysts. In patients who have dorsal wrist ganglions, the prevalence...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/kienbock-disease/intraosseous-ganglion.html"&gt;&lt;img src="http://www.johnnysilva.com/kienbock-disease/images/2050_30_46.jpg" style="width: 335pt; height: 148pt;" title="Fig Ulnocarpal impaction Plain radiographs show ulnar positive variance and subtle lytic lesions the lunate and triquetrum MRI confirms focal replacement the normal fatty marrow elements These changes may early the process ganglion cyst formation"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ajk4ISpdNt8:Pwpgy0x3Csg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ajk4ISpdNt8:Pwpgy0x3Csg:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Ajk4ISpdNt8:Pwpgy0x3Csg:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ajk4ISpdNt8:Pwpgy0x3Csg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Ajk4ISpdNt8:Pwpgy0x3Csg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Ajk4ISpdNt8:Pwpgy0x3Csg:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>KienbockDisease</category>
 <link>http://www.johnnysilva.com/kienbock-disease/intraosseous-ganglion.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/kienbock-disease/intraosseous-ganglion.html</guid>
 <media:content url="http://www.johnnysilva.com/kienbock-disease/images/2050_30_46.jpg" type="image/jpeg" height="207" width="469" />
 <media:title />
 <media:description type="html">Fig Ulnocarpal impaction Plain radiographs show ulnar positive variance and subtle lytic lesions the lunate and triquetrum MRI confirms focal replacement the normal fatty marrow elements These changes may early the process ganglion cyst formation</media:description>
 <pubDate>Tue, 21 Feb 2012 02:43:00 GMT</pubDate>
</item>
<item>
 <title>Methods 31 1 EnzymaticSynthesis</title>
 <description>1. Suspend the starch well in demineralized water. Maximum starch concentration recommended for this procedure is 2-5 by dry weight see Notes - and - . 2. Add approx 100 ppm of calcium see Note 9 . 3. Adjust the pH to 6.6. Take care to keep the starch granules in suspension, and allow up to 15 s in a well-mixed system for the pH to come into equilibrium see Note . 4. Heat the starch suspension from room temperature to 100 C in about 0.5 h under continuous stirring. Mix especially well when the...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uOKlPnbEjOg:YdS0q9wsBhk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uOKlPnbEjOg:YdS0q9wsBhk:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=uOKlPnbEjOg:YdS0q9wsBhk:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uOKlPnbEjOg:YdS0q9wsBhk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=uOKlPnbEjOg:YdS0q9wsBhk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=uOKlPnbEjOg:YdS0q9wsBhk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>EnzymaticSynthesis</category>
 <link>http://www.johnnysilva.com/enzymatic-synthesis/methods-31-1.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/enzymatic-synthesis/methods-31-1.html</guid>
 <pubDate>Tue, 21 Feb 2012 00:58:00 GMT</pubDate>
</item>
<item>
 <title>Materials 21 Ghz EnzymaticSynthesis</title>
 <description>1. Potato or tapioca starch, which can be obtained from one of the many starch producers like Avebe Veendam, The Netherlands or Emsland St rke Emlichheim, Experimental setup for preparing gelatinized starch. Experimental setup for preparing gelatinized starch. Germany , or from suppliers like Sigma. Starch may be stored at room temperature. There are differences between starches from different botanical sources see Note . 2. Heat-stable a-amylase from Bacillus licheniformis stored at 4 C see...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/enzymatic-synthesis/materials-21-ghz.html"&gt;&lt;img src="http://www.johnnysilva.com/enzymatic-synthesis/images/2035_63_48.jpg" style="width: 177pt; height: 239pt;"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=oiXvVlD3Zrw:cHclxF5QbdU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=oiXvVlD3Zrw:cHclxF5QbdU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=oiXvVlD3Zrw:cHclxF5QbdU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=oiXvVlD3Zrw:cHclxF5QbdU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=oiXvVlD3Zrw:cHclxF5QbdU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=oiXvVlD3Zrw:cHclxF5QbdU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>EnzymaticSynthesis</category>
 <link>http://www.johnnysilva.com/enzymatic-synthesis/materials-21-ghz.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/enzymatic-synthesis/materials-21-ghz.html</guid>
 <media:content url="http://www.johnnysilva.com/enzymatic-synthesis/images/2035_63_48.jpg" type="image/jpeg" height="335" width="248" />
 <media:title />
 <media:description type="html" />
 <pubDate>Tue, 21 Feb 2012 00:54:15 GMT</pubDate>
</item>
<item>
 <title>KCNH2 Splice Variants BrugadaSyndrome</title>
 <description>Several N-terminal splice variants of the human and mouse KCNH2 genes have been identified Kupershmidt et al. 1998 Lees-Miller et al. 1997 London et al. 1997 . The full-length KNCH2 isoform has 396 amino acids in the N-terminus and is designated isoform 1a. The alternatively spliced isoform 1b has a much shorter and divergent N-terminus of 36 amino acids. Isoform 1b lacks the sequence of amino acids 2-16 and the Per-Arnt-Sim PAS motif, which are both important for the slow deactivation process...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QNMcCXJfx8Y:ENWW14I_W_E:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QNMcCXJfx8Y:ENWW14I_W_E:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=QNMcCXJfx8Y:ENWW14I_W_E:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QNMcCXJfx8Y:ENWW14I_W_E:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=QNMcCXJfx8Y:ENWW14I_W_E:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=QNMcCXJfx8Y:ENWW14I_W_E:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BrugadaSyndrome</category>
 <link>http://www.johnnysilva.com/brugada-syndrome/kcnh2-splice-variants.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/brugada-syndrome/kcnh2-splice-variants.html</guid>
 <pubDate>Mon, 20 Feb 2012 23:44:12 GMT</pubDate>
</item>
<item>
 <title>Timemin CinnamonBark</title>
 <description>Figure 3-1 GLC chart of non-eugenol fraction of commercial cinnamon leaf oil on SCOT column. Figure 3.2 GLC chart of commercial cinnamon bark oil on SCOT column. Figure 3.2 GLC chart of commercial cinnamon bark oil on SCOT column. Following the development of solid injection techniques, Senanayake et al. 1975 , Wijesekera et al. 1975 and Wijesekera 1978 employed this methodology for the study of volatile constituents of morphologically distinct parts of the cinnamon tree, employing as little as...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/cinnamon-bark/timemin.html"&gt;&lt;img src="http://www.johnnysilva.com/cinnamon-bark/images/2112_41_31.png" style="width: 348pt; height: 187pt;" title="Figure GLC chart commercial cinnamon bark oil SCOT column"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0oTsuG910jk:dwQaViLIOIY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0oTsuG910jk:dwQaViLIOIY:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0oTsuG910jk:dwQaViLIOIY:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0oTsuG910jk:dwQaViLIOIY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=0oTsuG910jk:dwQaViLIOIY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=0oTsuG910jk:dwQaViLIOIY:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CinnamonBark</category>
 <link>http://www.johnnysilva.com/cinnamon-bark/timemin.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cinnamon-bark/timemin.html</guid>
 <media:content url="http://www.johnnysilva.com/cinnamon-bark/images/2112_41_31.png" type="image/png" height="262" width="487" />
 <media:title />
 <media:description type="html">Figure GLC chart commercial cinnamon bark oil SCOT column</media:description>
 <pubDate>Mon, 20 Feb 2012 23:38:40 GMT</pubDate>
</item>
<item>
 <title>C H A P T E R Tsw PeriodontalDisease</title>
 <description>WHAT DOES PERIODONTAL THERAPY ACCOMPLISH Local Therapy Systemic Therapy FACTORS THAT AFFECT HEALING Local Factors Systemic Factors HEALING AFTER PERIODONTAL THERAPY Regeneration Repair WHAT DOES PERIODONTAL THERAPY ACCOMPLISH T he effectiveness of periodontal therapy is made I possible by the remarkable healing capacity of the J_ periodontal tissues d ig. 36-1 . Periodontal therapy can restore chronically inflamed gingiva so that from a clinical and structural point of view it is almost...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=NbBHMKMdP5M:sVBQ8jd4100:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=NbBHMKMdP5M:sVBQ8jd4100:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=NbBHMKMdP5M:sVBQ8jd4100:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=NbBHMKMdP5M:sVBQ8jd4100:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=NbBHMKMdP5M:sVBQ8jd4100:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=NbBHMKMdP5M:sVBQ8jd4100:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PeriodontalDisease</category>
 <link>http://www.johnnysilva.com/periodontal-disease/c-h-a-p-t-e-r-tsw.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/periodontal-disease/c-h-a-p-t-e-r-tsw.html</guid>
 <pubDate>Mon, 20 Feb 2012 23:26:07 GMT</pubDate>
</item>
<item>
 <title>Absolute Relative and Attributable Risk BoneDensity</title>
 <description>As noted previously, incidence risk is also known as absolute risk. The term absolute risk will be used here. This is the number of individuals developing a disease within a specified period of time divided by the number of individuals at risk for the disease at the beginning of the time interval. In the context of this discussion, a certain level of bone density determines risk. The disease is fracture. For example, assume that 1000 women with the same level of bone density in the femoral neck...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=1K9qeYB20rY:SZzHp1OStIU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=1K9qeYB20rY:SZzHp1OStIU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=1K9qeYB20rY:SZzHp1OStIU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=1K9qeYB20rY:SZzHp1OStIU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=1K9qeYB20rY:SZzHp1OStIU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=1K9qeYB20rY:SZzHp1OStIU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>BoneDensity</category>
 <link>http://www.johnnysilva.com/bone-density/absolute-relative-and-attributable-risk.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/bone-density/absolute-relative-and-attributable-risk.html</guid>
 <pubDate>Mon, 20 Feb 2012 23:13:40 GMT</pubDate>
</item>
<item>
 <title>of the glenohumeral ligaments to the synovial recesses types of arrangement of the synovial recesses according to DePalma 29 RotatorCuff</title>
 <description>On the basis of a cadaver study of 108 shoulders, the variable topographical relationship of the glenohumeral ligaments to the synovial recesses Fig. 23 a gave rise to six distinct variations designs as Types I to VI. There are developmental types for they were present also in infant shoulders. However, because of progressive soft-tissue changes the different types may lose their distinguishing features. The size of both the superior and inferior subscapularis recess, regardless of the type in...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3nmfyDWNYwg:2qmvS3GAVb8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3nmfyDWNYwg:2qmvS3GAVb8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=3nmfyDWNYwg:2qmvS3GAVb8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3nmfyDWNYwg:2qmvS3GAVb8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=3nmfyDWNYwg:2qmvS3GAVb8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=3nmfyDWNYwg:2qmvS3GAVb8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>RotatorCuff</category>
 <link>http://www.johnnysilva.com/rotator-cuff/of-the-glenohumeral-ligaments-to-the-synovial-recesses-types-of-arrangement-of-the-synovial-recesses-according-to-depalma-[29.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/rotator-cuff/of-the-glenohumeral-ligaments-to-the-synovial-recesses-types-of-arrangement-of-the-synovial-recesses-according-to-depalma-[29.html</guid>
 <pubDate>Mon, 20 Feb 2012 22:31:53 GMT</pubDate>
</item>
<item>
 <title>Development Fig 199 ClinicalFeatures</title>
 <description>A small nodule, the tuberculum impar, is the first evidence of the developing tongue in the floor of the pharynx. This is soon covered over by the lingual swellings, one on each side, derived from the first branchial arch. These fuse in the midline to form the definitive anterior two-thirds of the tongue supplied by V and reinforced by chorda tympani. Posteriorly, this mass meets the copula or hypobranchial eminence , a central swelling in the pharyngeal floor which represents the 2nd, 3rd and...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/clinical-features/development-fig-199.html"&gt;&lt;img src="http://www.johnnysilva.com/clinical-features/images/2117_252_243-tuberculum-impar.jpg" style="width: 296pt; height: 148pt;" alt="Tuberculum Impar"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VPxJjfsarH0:ECW5bruOPyc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VPxJjfsarH0:ECW5bruOPyc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=VPxJjfsarH0:ECW5bruOPyc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VPxJjfsarH0:ECW5bruOPyc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=VPxJjfsarH0:ECW5bruOPyc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VPxJjfsarH0:ECW5bruOPyc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ClinicalFeatures</category>
 <link>http://www.johnnysilva.com/clinical-features/development-fig-199.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/clinical-features/development-fig-199.html</guid>
 <media:content url="http://www.johnnysilva.com/clinical-features/images/2117_252_243-tuberculum-impar.jpg" type="image/jpeg" height="207" width="414" />
 <media:title>Tuberculum Impar</media:title>
 <media:description type="html" />
 <pubDate>Mon, 20 Feb 2012 22:14:07 GMT</pubDate>
</item>
<item>
 <title>Peak Rigidity Age Groups ChildDevelopment</title>
 <description>To detect whether same-sex and opposite sex preferences change as a function of stereotype rigidity, children's preference scores were charted before and after their age of peak rigidity. Figure 13.5 displays the same-sex preference trends for girls and boys. In contrast to the flat preference trends observed when children were grouped according to chronological age, there appear to be clear developmental changes in children's same-sex preferences in relation to the degree to which they rigidly...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LX7UbgmAC3c:mVbhIIwTsd4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LX7UbgmAC3c:mVbhIIwTsd4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LX7UbgmAC3c:mVbhIIwTsd4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LX7UbgmAC3c:mVbhIIwTsd4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=LX7UbgmAC3c:mVbhIIwTsd4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=LX7UbgmAC3c:mVbhIIwTsd4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ChildDevelopment</category>
 <link>http://www.johnnysilva.com/child-development/peak-rigidity-age-groups.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/child-development/peak-rigidity-age-groups.html</guid>
 <pubDate>Mon, 20 Feb 2012 22:11:35 GMT</pubDate>
</item>
<item>
 <title>Iii Inhibitory Nk Receptors ImmuneResponses</title>
 <description>NK cells have long been known to resist killing of tumor cells that express MHC class I. The molecular basis for this restricted behavior lies in the expression of surface receptors that specifically recognize MHC class I alleles on target cells to deliver a signal cascade that inhibits, rather than activates, NK lytic function. It is only in the absence of such inhibitory receptors that NK cells can muster the killing of target cells mediated by activating receptors. Some exceptions exist...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l6T5uGQMUmg:b2-RrquIGsA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l6T5uGQMUmg:b2-RrquIGsA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=l6T5uGQMUmg:b2-RrquIGsA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l6T5uGQMUmg:b2-RrquIGsA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=l6T5uGQMUmg:b2-RrquIGsA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=l6T5uGQMUmg:b2-RrquIGsA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ImmuneResponses</category>
 <link>http://www.johnnysilva.com/immune-responses/iii-inhibitory-nk-receptors.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/immune-responses/iii-inhibitory-nk-receptors.html</guid>
 <pubDate>Mon, 20 Feb 2012 22:05:21 GMT</pubDate>
</item>
<item>
 <title>References Alu Molecular Biology 2</title>
 <description>Aboul-Enein, H.Y. ed. 1999 Analytical and Preparative Separation Methods of Biomacromolecules, Marcel Dekker, New York. Aguilar, M.-I. ed. 2004 HPLC of Peptides and Proteins, Humana Press, Totowa, NJ. Allen, R.C., Saravis, C.A. and Maurer, H.R. 1984 Gel Electrophoresis and Isoelectric Focusing of Proteins Selected Techniques, de Gruyter, Berlin. Andrews, A.T. 1986 Electrophoresis Theory, Techniques, and Biochemical and Clinical Applications, 2nd edn, Oxford University Press, New York. Andrews,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bt3o0qh9yVM:jRqgg1o8jds:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bt3o0qh9yVM:jRqgg1o8jds:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=bt3o0qh9yVM:jRqgg1o8jds:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bt3o0qh9yVM:jRqgg1o8jds:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=bt3o0qh9yVM:jRqgg1o8jds:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bt3o0qh9yVM:jRqgg1o8jds:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <link>http://www.johnnysilva.com/molecular-biology-2/references-alu.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/molecular-biology-2/references-alu.html</guid>
 <pubDate>Mon, 20 Feb 2012 21:02:39 GMT</pubDate>
</item>
<item>
 <title>Info Djm PhysicalExamination</title>
 <description>A smooth and often sore tongue that has lost its papillae suggests a deficiency in riboflavin, niacin, folic acid, vitamin B12, pyridoxine, or iron. Specific diagnosis is often difficult. Anticancer drugs may also be responsible. Whitish raised areas that have a feathery or corrugated pattern suggest hairy leukoplakia. Unlike candidiasis, these areas cannot be scraped off. The sides of the tongue are most often affected. This lesion is seen in HIV infection and AIDS. The thick white coat on...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/physical-examination/info-djm.html"&gt;&lt;img src="http://www.johnnysilva.com/physical-examination/images/1912_139_265-hairy-leukoplakia.jpg" style="width: 191pt; height: 120pt;" alt="Hairy Leukoplakia"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5viJ6TQeV1g:tUHdK31CF80:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5viJ6TQeV1g:tUHdK31CF80:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=5viJ6TQeV1g:tUHdK31CF80:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5viJ6TQeV1g:tUHdK31CF80:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=5viJ6TQeV1g:tUHdK31CF80:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=5viJ6TQeV1g:tUHdK31CF80:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>PhysicalExamination</category>
 <link>http://www.johnnysilva.com/physical-examination/info-djm.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/physical-examination/info-djm.html</guid>
 <media:content url="http://www.johnnysilva.com/physical-examination/images/1912_139_265-hairy-leukoplakia.jpg" type="image/jpeg" height="168" width="267" />
 <media:title>Hairy Leukoplakia</media:title>
 <media:description type="html" />
 <pubDate>Mon, 20 Feb 2012 20:11:29 GMT</pubDate>
</item>
<item>
 <title>References Bww ClinicalPearls</title>
 <description>Dluhy RG, Lawrence JE. Williams GH. Endocrine hypertension. In Larsen PR. Kronenberg HM. Melnied S. Polonsky KS, eds. Williams' textbook of endocrinology, l th ed. Philadelphia. WB Saunders, 2003 555-562. O'Connor DT. The adrenal medulla, catecholamines, and pheochromocytoma. In Goldman L. Bennett JC. eds. Cecil's textbook of medicine, 21st ed. Philadelphia. WB Saunders. 2000 1259-1262. Pacak K. Linehan WM. Eisenhofer G, et al. Recent advances in the diagnosis, localisation. and treatment of...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bv8YgrK0ApI:swAwoMxk-9o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bv8YgrK0ApI:swAwoMxk-9o:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=bv8YgrK0ApI:swAwoMxk-9o:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bv8YgrK0ApI:swAwoMxk-9o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=bv8YgrK0ApI:swAwoMxk-9o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=bv8YgrK0ApI:swAwoMxk-9o:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ClinicalPearls</category>
 <link>http://www.johnnysilva.com/clinical-pearls/references-bww.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/clinical-pearls/references-bww.html</guid>
 <pubDate>Mon, 20 Feb 2012 19:44:46 GMT</pubDate>
</item>
<item>
 <title>The parotid gland ClinicalFeatures</title>
 <description>This is the largest of the salivary glands, lying wedged between the Internal jugular vein, vagu and sympathetic chair Internal jugular vein, vagu and sympathetic chair Fig. 208 The parotid and its surrounds in a schematic horizontal section the facial nerve is the most superficial of the structures traversing the gland. The line of section is shown in the inset head. external carotid artery and retromandibular vein Fig. 208 The parotid and its surrounds in a schematic horizontal section the...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/clinical-features/the-parotid-gland.html"&gt;&lt;img src="http://www.johnnysilva.com/clinical-features/images/2117_269_253-facial-nerve-retromandibular-vein.jpg" style="width: 253pt; height: 193pt;" alt="Facial Nerve Retromandibular Vein"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Carqq55FZZ0:NoMO3cZiY4U:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Carqq55FZZ0:NoMO3cZiY4U:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Carqq55FZZ0:NoMO3cZiY4U:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Carqq55FZZ0:NoMO3cZiY4U:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Carqq55FZZ0:NoMO3cZiY4U:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Carqq55FZZ0:NoMO3cZiY4U:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>ClinicalFeatures</category>
 <link>http://www.johnnysilva.com/clinical-features/the-parotid-gland.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/clinical-features/the-parotid-gland.html</guid>
 <media:content url="http://www.johnnysilva.com/clinical-features/images/2117_269_253-facial-nerve-retromandibular-vein.jpg" type="image/jpeg" height="270" width="354" />
 <media:title>Facial Nerve Retromandibular Vein</media:title>
 <media:description type="html" />
 <pubDate>Mon, 20 Feb 2012 19:41:49 GMT</pubDate>
</item>
<item>
 <title>Info Erz CinnamonBark</title>
 <description>Figure 10.1 Young leaf of cinnamon damaged by cinnamon butterfly Chilasa clytia along with larva. Figure 10.1 Young leaf of cinnamon damaged by cinnamon butterfly Chilasa clytia along with larva. adversely affect plant growth. Infestation is more severe during December June when numerous tender flushes are present on the plants. The adults are large-sized butterflies with a wingspan of 90 mm and occur in two forms in the field, namely clytia and dissimilis. The form clytia mimics Euploea sp....&lt;p&gt;&lt;a href="http://www.johnnysilva.com/cinnamon-bark/info-erz.html"&gt;&lt;img src="http://www.johnnysilva.com/cinnamon-bark/images/2112_125_64.jpg" style="width: 197pt; height: 285pt;" title="Figure Young leaf cinnamon damaged cinnamon butterfly Chilasa clytia along with larva"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=XOPaUEMMWeg:a09Oalz2zwU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=XOPaUEMMWeg:a09Oalz2zwU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=XOPaUEMMWeg:a09Oalz2zwU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=XOPaUEMMWeg:a09Oalz2zwU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=XOPaUEMMWeg:a09Oalz2zwU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=XOPaUEMMWeg:a09Oalz2zwU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>CinnamonBark</category>
 <link>http://www.johnnysilva.com/cinnamon-bark/info-erz.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/cinnamon-bark/info-erz.html</guid>
 <media:content url="http://www.johnnysilva.com/cinnamon-bark/images/2112_125_64.jpg" type="image/jpeg" height="399" width="276" />
 <media:title />
 <media:description type="html">Figure Young leaf cinnamon damaged cinnamon butterfly Chilasa clytia along with larva</media:description>
 <pubDate>Mon, 20 Feb 2012 18:51:30 GMT</pubDate>
</item>
<item>
 <title>Info Xjm OpticNerve</title>
 <description>All types of movement affected saccadic, pursuit, vestibulo-ocular , exophthalmos possible Certain types of movement more or less affected than others supranuclear disease Exophthalmos and or inflammation of orbital tissues No exophthalmos, no inflammation of orbital tissues Diff Dx chronic progressive external ophthalmoplegia, Graves'disease, myasthenia Diff Dx demyelination, infarction, neoplasm, degeneration e.g., progressive supranuclear paralysis, or PSP Diff Dx aneurysm, tumor, ischemic...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4-zzQFkqQOA:OgmJP75jggM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4-zzQFkqQOA:OgmJP75jggM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=4-zzQFkqQOA:OgmJP75jggM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4-zzQFkqQOA:OgmJP75jggM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=4-zzQFkqQOA:OgmJP75jggM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=4-zzQFkqQOA:OgmJP75jggM:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>OpticNerve</category>
 <link>http://www.johnnysilva.com/optic-nerve/info-xjm.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/optic-nerve/info-xjm.html</guid>
 <pubDate>Mon, 20 Feb 2012 18:49:43 GMT</pubDate>
</item>
<item>
 <title>Info Rfb RheumatoidArthritis</title>
 <description>5.6. Inspection 6 The carrying angle may be measured with a goniometer. Average values of carrying angle Males 11 range 2 -26 Females 13 range 2 -22 . 5.7. Movements 1 Extension A Full extension, 0 , is present if the arm and forearm can be made to lie in a straight line. B Loss of full extension is especially common in osteoarthritis, rheumatoid arthritis, and old fractures particularly of the radial head involving the elbow joint. 5.8. Movements 2 Hyperextension If the elbow can he extended...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/rheumatoid-arthritis/info-rfb.html"&gt;&lt;img src="http://www.johnnysilva.com/rheumatoid-arthritis/images/2132_14_241.jpg" style="width: 367pt; height: 176pt;" title=" Ulnar nerve Palpate again and note the extent any tenderness and whether the nerve thickened Look again for cubitus valgus Look for evidence ulnar nerve palsy"/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Piu7bSDy148:-8iaDHYPwpc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Piu7bSDy148:-8iaDHYPwpc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Piu7bSDy148:-8iaDHYPwpc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Piu7bSDy148:-8iaDHYPwpc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=Piu7bSDy148:-8iaDHYPwpc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=Piu7bSDy148:-8iaDHYPwpc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>RheumatoidArthritis</category>
 <link>http://www.johnnysilva.com/rheumatoid-arthritis/info-rfb.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/rheumatoid-arthritis/info-rfb.html</guid>
 <media:content url="http://www.johnnysilva.com/rheumatoid-arthritis/images/2132_14_241.jpg" type="image/jpeg" height="246" width="514" />
 <media:title />
 <media:description type="html"> Ulnar nerve Palpate again and note the extent any tenderness and whether the nerve thickened Look again for cubitus valgus Look for evidence ulnar nerve palsy</media:description>
 <pubDate>Mon, 20 Feb 2012 17:47:20 GMT</pubDate>
</item>
<item>
 <title>Synthesis Of Dendrimers And Hyperbranched Polymers MagneticNanoparticles</title>
 <description>The well-defined architecture of dendrimers arises from the stepwise synthetic procedure consisting of a series of coupling and activation steps. The synthesis of dendrimers follow either a divergent or a convergent growth strategy 4-7 . In the divergent approach Figure 5.2a , the dendrimer grows outwards from the core, each generation at a time. Divergent growth is useful for the production of large quantities of dendrimers, since the molar mass is doubled after each generation. However,...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FpAjx01GTkw:8OI1I5VUUaA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FpAjx01GTkw:8OI1I5VUUaA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=FpAjx01GTkw:8OI1I5VUUaA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FpAjx01GTkw:8OI1I5VUUaA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=FpAjx01GTkw:8OI1I5VUUaA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=FpAjx01GTkw:8OI1I5VUUaA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>MagneticNanoparticles</category>
 <link>http://www.johnnysilva.com/magnetic-nanoparticles/synthesis-of-dendrimers-and-hyperbranched-polymers.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/magnetic-nanoparticles/synthesis-of-dendrimers-and-hyperbranched-polymers.html</guid>
 <pubDate>Mon, 20 Feb 2012 17:16:49 GMT</pubDate>
</item>
<item>
 <title>Pressure autoregulation VascularResistance</title>
 <description>Flow is locally controlled in certain vascular beds by a process termed autoregulation36 Fig. 6.5 . By definition, autoregulation is the ability of an organ to maintain a relatively constant blood flow in the presence of changes in arterial perfusion pressure. The kidneys, brain, and heart are organs that exhibit autoregulation, whereas the skin and lungs are organs with minimal ability for autoregulation. Fig 6.5 Pressure autoregulation in the normal coronary circulation. Note that during...&lt;p&gt;&lt;a href="http://www.johnnysilva.com/vascular-resistance/pressure-autoregulation.html"&gt;&lt;img src="http://www.johnnysilva.com/vascular-resistance/images/2044_118_62.jpg" style="width: 367pt; height: 271pt;" title="Fig Pressure autoregulation the normal coronary circulation Note that during maximum vasodilation autoregulation abolished dashed line and pressure flow relationships resemble those rigid elastic tube Reprinted with permission from Goldberg and Warltier "/&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IdefVEM3JwU:P2mmHvkSa_s:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IdefVEM3JwU:P2mmHvkSa_s:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=IdefVEM3JwU:P2mmHvkSa_s:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IdefVEM3JwU:P2mmHvkSa_s:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=IdefVEM3JwU:P2mmHvkSa_s:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=IdefVEM3JwU:P2mmHvkSa_s:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>VascularResistance</category>
 <link>http://www.johnnysilva.com/vascular-resistance/pressure-autoregulation.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/vascular-resistance/pressure-autoregulation.html</guid>
 <media:content url="http://www.johnnysilva.com/vascular-resistance/images/2044_118_62.jpg" type="image/jpeg" height="379" width="514" />
 <media:title />
 <media:description type="html">Fig Pressure autoregulation the normal coronary circulation Note that during maximum vasodilation autoregulation abolished dashed line and pressure flow relationships resemble those rigid elastic tube Reprinted with permission from Goldberg and Warltier </media:description>
 <pubDate>Mon, 20 Feb 2012 17:07:58 GMT</pubDate>
</item>
<item>
 <title>Info Ngd NervousSystem</title>
 <description>Beta receptor. adrenergic receptor sites associated with adenylate cyclase in appropriate postsynaptic membranes, but not identical with it binding preferentially to adrenaline rather than noradrenaline. Heart muscle has beta receptors predominantly which result in 'increased heart rate and blood pressure when stimulated other beta effects include dilation of arterioles supplying skeletal muscle, bronchial relaxation and relaxation of the uterus. All these effects are mimicked by the synthetic...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VtINiKUVXI8:DhmG2cdLJ70:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VtINiKUVXI8:DhmG2cdLJ70:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=VtINiKUVXI8:DhmG2cdLJ70:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VtINiKUVXI8:DhmG2cdLJ70:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?i=VtINiKUVXI8:DhmG2cdLJ70:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/CancerResearcher?a=VtINiKUVXI8:DhmG2cdLJ70:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/CancerResearcher?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description>
 <category>NervousSystem</category>
 <link>http://www.johnnysilva.com/nervous-system/info-ngd.html</link>
 <guid isPermaLink="true">http://www.johnnysilva.com/nervous-system/info-ngd.html</guid>
 <pubDate>Mon, 20 Feb 2012 16:50:38 GMT</pubDate>
</item>
 
</channel>

</rss>

